-
1
-
-
33745661675
-
Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials
-
1:CAS:528:DC%2BD28Xms1Gkt7k%3D 16824829
-
Stettler C, Allemann S, Jüni P, Cull CA, Holman RR, Egger M, Krähenbühl S, Diem P. Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials. Am Heart J. 2006;152:27-38.
-
(2006)
Am Heart J
, vol.152
, pp. 27-38
-
-
Stettler, C.1
Allemann, S.2
Jüni, P.3
Cull, C.A.4
Holman, R.R.5
Egger, M.6
Krähenbühl, S.7
Diem, P.8
-
2
-
-
78649326062
-
Type 2 diabetes mellitus as a risk factor for the onset of depression: A systematic review and meta-analysis
-
1:STN:280:DC%2BC3cbnsVWmsQ%3D%3D 20711716 2974923
-
Nouwen A, Winkley K, Twisk J, Lloyd CE, Peyrot M, Ismail K, Pouwer F. Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Diabetologia. 2010;53:2480-6.
-
(2010)
Diabetologia
, vol.53
, pp. 2480-2486
-
-
Nouwen, A.1
Winkley, K.2
Twisk, J.3
Lloyd, C.E.4
Peyrot, M.5
Ismail, K.6
Pouwer, F.7
-
3
-
-
2342447295
-
Diabetes, depression, and quality of life: A population study
-
15111522
-
Goldney RD, Phillips PJ, Fisher LJ, Wilson DH. Diabetes, depression, and quality of life: a population study. Diabetes Care. 2004;27:1066-70.
-
(2004)
Diabetes Care
, vol.27
, pp. 1066-1070
-
-
Goldney, R.D.1
Phillips, P.J.2
Fisher, L.J.3
Wilson, D.H.4
-
4
-
-
0141988862
-
Importance of weight management in Type 2 diabetes: Review with meta-analysis of clinical studies
-
14559925
-
Anderson JW, Kendall CWC, Jenkins DJA. Importance of weight management in Type 2 diabetes: review with meta-analysis of clinical studies. J Am Coll Nutr. 2003;22:331-9.
-
(2003)
J Am Coll Nutr
, vol.22
, pp. 331-339
-
-
Anderson, J.W.1
Kendall, C.W.C.2
Jenkins, D.J.A.3
-
5
-
-
62849107573
-
Body-mass index and cause-specific mortality in 900 000 adults: Collaborative analyses of 57 prospective studies
-
19299006
-
Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, Qizilbash N, Collins R, Peto R. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373:1083-96.
-
(2009)
Lancet
, vol.373
, pp. 1083-1096
-
-
Whitlock, G.1
Lewington, S.2
Sherliker, P.3
Clarke, R.4
Emberson, J.5
Halsey, J.6
Qizilbash, N.7
Collins, R.8
Peto, R.9
-
6
-
-
51849146897
-
Global burden of obesity in 2005 and projections to 2030
-
1:STN:280:DC%2BD1cngsVamtQ%3D%3D
-
Kelly T, Yang W, Chen C-S, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond). 2008;32:1431-7.
-
(2008)
Int J Obes (Lond)
, vol.32
, pp. 1431-1437
-
-
Kelly, T.1
Yang, W.2
Chen, C.-S.3
Reynolds, K.4
He, J.5
-
7
-
-
2342466734
-
Global Prevalence of Diabetes: Estimates for the year 2000 and projections for 2030
-
15111519
-
Wild S, Roglic G, Green A, Sicree R, King H. Global Prevalence of Diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047-53.
-
(2004)
Diabetes Care
, vol.27
, pp. 1047-1053
-
-
Wild, S.1
Roglic, G.2
Green, A.3
Sicree, R.4
King, H.5
-
8
-
-
67650757447
-
The energy balance equation: Looking back and looking forward are two very different views
-
19386028
-
Schoeller D a. The energy balance equation: looking back and looking forward are two very different views. Nutr Rev. 2009;67:249-54.
-
(2009)
Nutr Rev
, vol.67
, pp. 249-254
-
-
Schoeller, D.A.1
-
9
-
-
34547415714
-
Appetite control after weight loss: What is the role of bloodborne peptides?
-
1:CAS:528:DC%2BD2sXos1Sgs7w%3D 17510692
-
Doucet É, Cameron J. Appetite control after weight loss: what is the role of bloodborne peptides? Appl Physiol Nutr Metab. 2007;32:523-32.
-
(2007)
Appl Physiol Nutr Metab
, vol.32
, pp. 523-532
-
-
Doucet, É.1
Cameron, J.2
-
10
-
-
35748957503
-
The physiology of glucagon-like peptide 1
-
1:CAS:528:DC%2BD2sXhtlaqu7jI 17928588
-
Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev. 2007;87:1409-39.
-
(2007)
Physiol Rev
, vol.87
, pp. 1409-1439
-
-
Holst, J.J.1
-
11
-
-
84859478593
-
G-protein-coupled receptors in intestinal chemosensation
-
1:CAS:528:DC%2BC38XlsVaiu7o%3D 22482725
-
Reimann F, Tolhurst G, Gribble FM. G-protein-coupled receptors in intestinal chemosensation. Cell Metab. 2012;15:421-31.
-
(2012)
Cell Metab
, vol.15
, pp. 421-431
-
-
Reimann, F.1
Tolhurst, G.2
Gribble, F.M.3
-
12
-
-
79959911030
-
Classification and functions of enteroendocrine cells of the lower gastrointestinal tract
-
1:CAS:528:DC%2BC3MXhtV2qsbvL 21518048 3144510
-
Gunawardene AR, Corfe BM, Staton CA. Classification and functions of enteroendocrine cells of the lower gastrointestinal tract. Int J Exp Pathol. 2011;92:219-31.
-
(2011)
Int J Exp Pathol
, vol.92
, pp. 219-231
-
-
Gunawardene, A.R.1
Corfe, B.M.2
Staton, C.A.3
-
13
-
-
0022509255
-
Cellular localization of proglucagon/glucagon-like peptide i messenger RNAs in rat brain
-
1:CAS:528:DyaL28XlsVKlur4%3D 2427741
-
Han VK, Hynes MA, Jin C, Towle AC, Lauder JM, Lund PK. Cellular localization of proglucagon/glucagon-like peptide I messenger RNAs in rat brain. J Neurosci Res. 1986;16:97-107.
-
(1986)
J Neurosci Res
, vol.16
, pp. 97-107
-
-
Han, V.K.1
Hynes, M.A.2
Jin, C.3
Towle, A.C.4
Lauder, J.M.5
Lund, P.K.6
-
14
-
-
0031029936
-
Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem
-
1:CAS:528:DyaK2sXht1antrs%3D 9044391
-
Larsen P, Tang-Christensen M, Holst J, Ørskov C. Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem. Neuroscience. 1997;77:257-70.
-
(1997)
Neuroscience
, vol.77
, pp. 257-270
-
-
Larsen, P.1
Tang-Christensen, M.2
Holst, J.3
Ørskov, C.4
-
15
-
-
0030012124
-
Role of prohormone convertases in the tissue-specific processing of proglucagon
-
1:CAS:528:DyaK28XitFSlt7g%3D 8721980
-
Dhanvantari S, Seidah NG, Brubaker PL. Role of prohormone convertases in the tissue-specific processing of proglucagon. Mol Endocrinol. 1996;10:342-55.
-
(1996)
Mol Endocrinol
, vol.10
, pp. 342-355
-
-
Dhanvantari, S.1
Seidah, N.G.2
Brubaker, P.L.3
-
16
-
-
0024064749
-
Proglucagon-derived peptides: Nomenclature, biosynthetic relationships and physiological roles
-
1:CAS:528:DyaL1cXmtVCqsbY%3D 3065110
-
Conlon J. Proglucagon-derived peptides: nomenclature, biosynthetic relationships and physiological roles. Diabetologia. 1988;31:563-6.
-
(1988)
Diabetologia
, vol.31
, pp. 563-566
-
-
Conlon, J.1
-
17
-
-
0023008693
-
Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing
-
1:CAS:528:DyaL28XlsVOntr0%3D 3528148
-
Mojsov S, Heinrich G, Wilson IB, Ravazzola M, Orci L, Habener JF. Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing. J Biol Chem. 1986;261:11880-9.
-
(1986)
J Biol Chem
, vol.261
, pp. 11880-11889
-
-
Mojsov, S.1
Heinrich, G.2
Wilson, I.B.3
Ravazzola, M.4
Orci, L.5
Habener, J.F.6
-
18
-
-
0023161473
-
Identical mRNA for preproglucagon in pancreas and gut
-
1:CAS:528:DyaL2sXitVyktLk%3D 3569278
-
Novak U, Wilks A, Buell G, McEwen S. Identical mRNA for preproglucagon in pancreas and gut. Eur J Biochem. 1987;164:553-8.
-
(1987)
Eur J Biochem
, vol.164
, pp. 553-558
-
-
Novak, U.1
Wilks, A.2
Buell, G.3
McEwen, S.4
-
19
-
-
0342748342
-
Proglucagon processing in islet and intestinal cell lines
-
1:CAS:528:DyaK28XjtFWit7c%3D 8738879
-
Tucker JD, Dhanvantari S, Brubaker PL. Proglucagon processing in islet and intestinal cell lines. Regul Pept. 1996;62:29-35.
-
(1996)
Regul Pept
, vol.62
, pp. 29-35
-
-
Tucker, J.D.1
Dhanvantari, S.2
Brubaker, P.L.3
-
20
-
-
0029937684
-
Release of glucagon-like peptide 1 (GLP-1 [7-36 amide]), gastric inhibitory polypeptide (GIP) and insulin in response to oral glucose after upper and lower intestinal resections
-
1:CAS:528:DyaK28XisVOntrk%3D 8650968
-
Nauck MA, Siemsglüss J, Orskov C, Holst JJ. Release of glucagon-like peptide 1 (GLP-1 [7-36 amide]), gastric inhibitory polypeptide (GIP) and insulin in response to oral glucose after upper and lower intestinal resections. Z Gastroenterol. 1996;34:159-66.
-
(1996)
Z Gastroenterol
, vol.34
, pp. 159-166
-
-
Nauck, M.A.1
Siemsglüss, J.2
Orskov, C.3
Holst, J.J.4
-
21
-
-
0028953577
-
Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo
-
1:CAS:528:DyaK2MXktlOnurw%3D 7883856
-
Deacon CF, Johnsen AH, Holst JJ. Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo. J Clin Endocrinol Metab. 1995;80:952-7.
-
(1995)
J Clin Endocrinol Metab
, vol.80
, pp. 952-957
-
-
Deacon, C.F.1
Johnsen, A.H.2
Holst, J.J.3
-
22
-
-
0029797540
-
Glucagon-like peptide 1 undergoes differential tissue-specific metabolism in the anesthetized pig
-
1:CAS:528:DyaK28XmtFajtrk%3D
-
Deacon CF, Pridal L, Klarskov L, Olesen M, Holst JJ. Glucagon-like peptide 1 undergoes differential tissue-specific metabolism in the anesthetized pig. Am J Physiol Endocrinol Metab. 1996;271:E458-464.
-
(1996)
Am J Physiol Endocrinol Metab
, vol.271
, pp. E458-E464
-
-
Deacon, C.F.1
Pridal, L.2
Klarskov, L.3
Olesen, M.4
Holst, J.J.5
-
23
-
-
0033303516
-
Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine
-
1:CAS:528:DyaK1MXmvFemtbs%3D 10537167
-
Hansen L, Deacon CF, Orskov C, Holst JJ. Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine. Endocrinology. 1999;140:5356-63.
-
(1999)
Endocrinology
, vol.140
, pp. 5356-5363
-
-
Hansen, L.1
Deacon, C.F.2
Orskov, C.3
Holst, J.J.4
-
24
-
-
0022461548
-
Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses
-
1:CAS:528:DyaL28XkvFWkt7g%3D 3522621
-
Nauck MA, Homberger E, Siegel EG, Allen RC, Eaton RP, Ebert R, Creutzfeldt W. Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses. J Clin Endocrinol Metab. 1986;63:492-8.
-
(1986)
J Clin Endocrinol Metab
, vol.63
, pp. 492-498
-
-
Nauck, M.A.1
Homberger, E.2
Siegel, E.G.3
Allen, R.C.4
Eaton, R.P.5
Ebert, R.6
Creutzfeldt, W.7
-
25
-
-
0029765475
-
Secretion of the incretin hormones glucagon-like peptide-1 and gastric inhibitory polypeptide correlates with insulin secretion in normal man throughout the day
-
1:STN:280:DyaK28vhs1ejuw%3D%3D 8819215
-
Orskov C, Wettergren A, Holst JJ. Secretion of the incretin hormones glucagon-like peptide-1 and gastric inhibitory polypeptide correlates with insulin secretion in normal man throughout the day. Scand J Gastroenterol. 1996;31:665-70.
-
(1996)
Scand J Gastroenterol
, vol.31
, pp. 665-670
-
-
Orskov, C.1
Wettergren, A.2
Holst, J.J.3
-
26
-
-
0032960834
-
Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: Studies with the antagonist exendin 9-39
-
1:CAS:528:DyaK1MXhvV2qtQ%3D%3D 9892226
-
Edwards CM, Todd JF, Mahmoudi M, Wang Z, Wang RM, Ghatei MA, Bloom SR. Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39. Diabetes. 1999;48:86-93.
-
(1999)
Diabetes
, vol.48
, pp. 86-93
-
-
Edwards, C.M.1
Todd, J.F.2
Mahmoudi, M.3
Wang, Z.4
Wang, R.M.5
Ghatei, M.A.6
Bloom, S.R.7
-
27
-
-
0028821658
-
Glucagon-like peptide-1 is a physiological incretin in rat
-
1:CAS:528:DyaK2MXivFyks7w%3D 7814643 295450
-
Wang Z, Wang RM, Owji AA, Smith DM, Ghatei MA, Bloom SR. Glucagon-like peptide-1 is a physiological incretin in rat. J Clin Invest. 1995;95:417-21.
-
(1995)
J Clin Invest
, vol.95
, pp. 417-421
-
-
Wang, Z.1
Wang, R.M.2
Owji, A.A.3
Smith, D.M.4
Ghatei, M.A.5
Bloom, S.R.6
-
28
-
-
0344357096
-
Glucagon-like peptide i stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line
-
1:CAS:528:DyaL2sXktlelsLk%3D 3033647 304885
-
Drucker DJ, Philippe J, Mojsov S, Chick WL, Habener JF. Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. Proc Natl Acad Sci U S A. 1987;84:3434-8.
-
(1987)
Proc Natl Acad Sci U S A
, vol.84
, pp. 3434-3438
-
-
Drucker, D.J.1
Philippe, J.2
Mojsov, S.3
Chick, W.L.4
Habener, J.F.5
-
29
-
-
0022617246
-
Reduced incretin effect in Type 2 (non-insulin-dependent) diabetes
-
1:STN:280:DyaL287msFCmuw%3D%3D 3514343
-
Nauck M, Stöckmann F, Ebert R, Creutzfeldt W. Reduced incretin effect in Type 2 (non-insulin-dependent) diabetes. Diabetologia. 1986;29:46-52.
-
(1986)
Diabetologia
, vol.29
, pp. 46-52
-
-
Nauck, M.1
Stöckmann, F.2
Ebert, R.3
Creutzfeldt, W.4
-
30
-
-
0020549057
-
Discrepancy between plasma C-peptide and insulin response to oral and intravenous glucose
-
1:CAS:528:DyaL3sXlsFamu78%3D 6341127
-
Madsbad S, Kehlet H, Hilsted J, Tronier B. Discrepancy between plasma C-peptide and insulin response to oral and intravenous glucose. Diabetes. 1983;32:436-8.
-
(1983)
Diabetes
, vol.32
, pp. 436-438
-
-
Madsbad, S.1
Kehlet, H.2
Hilsted, J.3
Tronier, B.4
-
31
-
-
3242730474
-
Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans
-
1:CAS:528:DC%2BD2cXmvVKnt78%3D
-
Holst JJ. Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans. AJP Endocrinol Metab. 2004;287:E199-206.
-
(2004)
AJP Endocrinol Metab
, vol.287
, pp. E199-E206
-
-
Holst, J.J.1
-
32
-
-
0032868694
-
Insulin inhibits glucagon secretion by the activation of PI3-kinase in In-R1-G9 cells
-
1:CAS:528:DyaK1MXjtFWqsbo%3D 10414926
-
Kaneko K, Shirotani T, Araki E, Matsumoto K, Taguchi T, Motoshima H, Yoshizato K, Kishikawa H, Shichiri M. Insulin inhibits glucagon secretion by the activation of PI3-kinase in In-R1-G9 cells. Diabetes Res Clin Pract. 1999;44:83-92.
-
(1999)
Diabetes Res Clin Pract
, vol.44
, pp. 83-92
-
-
Kaneko, K.1
Shirotani, T.2
Araki, E.3
Matsumoto, K.4
Taguchi, T.5
Motoshima, H.6
Yoshizato, K.7
Kishikawa, H.8
Shichiri, M.9
-
33
-
-
0021711003
-
Insulin within islets is a physiologic glucagon release inhibitor
-
1:CAS:528:DyaL2MXptVelsw%3D%3D 6392344 425424
-
Maruyama H, Hisatomi A, Orci L, Grodsky GM, Unger RH. Insulin within islets is a physiologic glucagon release inhibitor. J Clin Invest. 1984;74:2296-9.
-
(1984)
J Clin Invest
, vol.74
, pp. 2296-2299
-
-
Maruyama, H.1
Hisatomi, A.2
Orci, L.3
Grodsky, G.M.4
Unger, R.H.5
-
34
-
-
55649108863
-
Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas
-
1:CAS:528:DC%2BD1cXhtlCjs7zM 18795252
-
De Heer J, Rasmussen C, Coy DH, Holst JJ. Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas. Diabetologia. 2008;51:2263-70.
-
(2008)
Diabetologia
, vol.51
, pp. 2263-2270
-
-
De Heer, J.1
Rasmussen, C.2
Coy, D.H.3
Holst, J.J.4
-
35
-
-
0031913829
-
Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat
-
1:CAS:528:DyaK1cXhs1aqtb8%3D 9519740
-
Pick A, Clark J, Kubstrup C, Levisetti M, Pugh W, Bonner-Weir S, Polonsky KS. Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat. Diabetes. 1998;47:358-64.
-
(1998)
Diabetes
, vol.47
, pp. 358-364
-
-
Pick, A.1
Clark, J.2
Kubstrup, C.3
Levisetti, M.4
Pugh, W.5
Bonner-Weir, S.6
Polonsky, K.S.7
-
36
-
-
0037414781
-
Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis
-
1:CAS:528:DC%2BD38XpvVWgu78%3D 12409292
-
Li Y, Hansotia T, Yusta B, Ris F, Halban PA, Drucker DJ. Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis. J Biol Chem. 2003;278:471-8.
-
(2003)
J Biol Chem
, vol.278
, pp. 471-478
-
-
Li, Y.1
Hansotia, T.2
Yusta, B.3
Ris, F.4
Halban, P.A.5
Drucker, D.J.6
-
37
-
-
0036828227
-
Glucagon-Like Peptide-1 Promotes Islet cell growth and inhibits apoptosis in Zucker diabetic Rats
-
Farilla L, Hui H, Bertolotto C, Kang E, Bulotta A, Di Mario U, Perfetti R. Glucagon-Like Peptide-1 Promotes Islet cell growth and inhibits apoptosis in Zucker diabetic Rats. Endocrinology. 2013;143:4397-408.
-
(2013)
Endocrinology
, vol.143
, pp. 4397-4408
-
-
Farilla, L.1
Hui, H.2
Bertolotto, C.3
Kang, E.4
Bulotta, A.5
Di Mario, U.6
Perfetti, R.7
-
38
-
-
0034522773
-
Glucagon-Like Peptide-1 induces cell proliferation and Pancreatic-Duodenum Homeobox-1 expression and increases endocrine cell mass in the pancreas of old, Glucose-Intolerant Rats
-
Perfetti R, Zhou J, Doyle ME, Egan JM. Glucagon-Like Peptide-1 induces cell proliferation and Pancreatic-Duodenum Homeobox-1 expression and increases endocrine cell mass in the pancreas of old, Glucose-Intolerant Rats. Endocrinology. 2013;141:4600-5.
-
(2013)
Endocrinology
, vol.141
, pp. 4600-4605
-
-
Perfetti, R.1
Zhou, J.2
Doyle, M.E.3
Egan, J.M.4
-
39
-
-
84888205217
-
Brain regulation of energy balance and body weight
-
1:CAS:528:DC%2BC3sXhslaktr%2FL 23990408
-
Rui L. Brain regulation of energy balance and body weight. Rev Endocr Metab Disord. 2013;14:387-407.
-
(2013)
Rev Endocr Metab Disord
, vol.14
, pp. 387-407
-
-
Rui, L.1
-
40
-
-
84901006228
-
Neurobiology of food intake in health and disease
-
1:CAS:528:DC%2BC2cXotFylt70%3D 24840801 4076116
-
Morton GJ, Meek TH, Schwartz MW. Neurobiology of food intake in health and disease. Nat Rev Neurosci. 2014;15:367-78.
-
(2014)
Nat Rev Neurosci
, vol.15
, pp. 367-378
-
-
Morton, G.J.1
Meek, T.H.2
Schwartz, M.W.3
-
41
-
-
0030056878
-
Expression of the glucagon-like peptide-1 receptor gene in rat brain
-
1:CAS:528:DyaK28Xht1entbY%3D 8769850
-
Alvarez E, Roncero I, Chowen JA, Thorens B, Blázquez E. Expression of the glucagon-like peptide-1 receptor gene in rat brain. J Neurochem. 1996;66:920-7.
-
(1996)
J Neurochem
, vol.66
, pp. 920-927
-
-
Alvarez, E.1
Roncero, I.2
Chowen, J.A.3
Thorens, B.4
Blázquez, E.5
-
42
-
-
0033545166
-
Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system
-
1:CAS:528:DyaK1MXhtlWntw%3D%3D 9886047
-
Merchenthaler I, Lane M, Shughrue P. Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system. J Comp Neurol. 1999;403:261-80.
-
(1999)
J Comp Neurol
, vol.403
, pp. 261-280
-
-
Merchenthaler, I.1
Lane, M.2
Shughrue, P.3
-
43
-
-
34748898831
-
Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats
-
1:CAS:528:DC%2BD2sXhtFWls7bP 17584962
-
Vahl TP, Tauchi M, Durler TS, Elfers EE, Fernandes TM, Bitner RD, Ellis KS, Woods SC, Seeley RJ, Herman JP, D'Alessio DA. Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats. Endocrinology. 2007;148:4965-73.
-
(2007)
Endocrinology
, vol.148
, pp. 4965-4973
-
-
Vahl, T.P.1
Tauchi, M.2
Durler, T.S.3
Elfers, E.E.4
Fernandes, T.M.5
Bitner, R.D.6
Ellis, K.S.7
Woods, S.C.8
Seeley, R.J.9
Herman, J.P.10
D'Alessio, D.A.11
-
44
-
-
0028867442
-
Distribution of GLP-1 Binding sites in the Rat brain: Evidence that Exendin-4 is a Ligand of Brain GLP-1 Binding Sites
-
8563978
-
Göke R, Larsen PJ, Mikkelsen JD, Sheikh SP. Distribution of GLP-1 Binding sites in the Rat brain: evidence that Exendin-4 is a Ligand of Brain GLP-1 Binding Sites. Eur J Neurosci. 1995;7:2294-300.
-
(1995)
Eur J Neurosci
, vol.7
, pp. 2294-2300
-
-
Göke, R.1
Larsen, P.J.2
Mikkelsen, J.D.3
Sheikh, S.P.4
-
45
-
-
0029903111
-
Glucagon-like peptide i receptors in the subfornical organ and the area postrema are accessible to circulating glucagon-like peptide i
-
1:STN:280:DyaK283itVSruw%3D%3D 8635662
-
Orskov C, Poulsen SS, Møller M, Holst JJ. Glucagon-like peptide I receptors in the subfornical organ and the area postrema are accessible to circulating glucagon-like peptide I. Diabetes. 1996;45:832-5.
-
(1996)
Diabetes
, vol.45
, pp. 832-835
-
-
Orskov, C.1
Poulsen, S.S.2
Møller, M.3
Holst, J.J.4
-
46
-
-
84907495472
-
The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss
-
1:CAS:528:DC%2BC2cXhslGgtrrJ 25202980 4215190
-
Secher A, Jelsing J, Baquero AF, Hecksher-Sørensen J, Cowley MA, Dalbøge LS, Hansen G, Grove KL, Pyke C, Raun K, Schäffer L, Tang-Christensen M, Verma S, Witgen BM, Vrang N, Bjerre KL. The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss. J Clin Invest. 2014;124:4473-88.
-
(2014)
J Clin Invest
, vol.124
, pp. 4473-4488
-
-
Secher, A.1
Jelsing, J.2
Baquero, A.F.3
Hecksher-Sørensen, J.4
Cowley, M.A.5
Dalbøge, L.S.6
Hansen, G.7
Grove, K.L.8
Pyke, C.9
Raun, K.10
Schäffer, L.11
Tang-Christensen, M.12
Verma, S.13
Witgen, B.M.14
Vrang, N.15
Bjerre, K.L.16
-
47
-
-
84907059436
-
Long term exendin-4 treatment reduces food intake and body weight and alters expression of brain homeostatic and reward markers
-
24949661 4138563
-
Yang Y, Moghadam AA, Cordner ZA, Liang N-C, Moran TH. Long term exendin-4 treatment reduces food intake and body weight and alters expression of brain homeostatic and reward markers. Endocrinology. 2014;155:3473-83.
-
(2014)
Endocrinology
, vol.155
, pp. 3473-3483
-
-
Yang, Y.1
Moghadam, A.A.2
Cordner, Z.A.3
Liang, N.-C.4
Moran, T.H.5
-
48
-
-
84888201465
-
Enteroendocrine cell signalling via the vagus nerve
-
1:CAS:528:DC%2BC3sXhsV2mu7%2FK 24064396
-
Dockray GJ. Enteroendocrine cell signalling via the vagus nerve. Curr Opin Pharmacol. 2013;13:954-8.
-
(2013)
Curr Opin Pharmacol
, vol.13
, pp. 954-958
-
-
Dockray, G.J.1
-
49
-
-
0842325280
-
Receptor gene expression of glucagon-like peptide-1, but not glucose-dependent insulinotropic polypeptide, in rat nodose ganglion cells
-
1:CAS:528:DC%2BD2cXps1yrtQ%3D%3D 14766323
-
Nakagawa A, Satake H, Nakabayashi H, Nishizawa M, Furuya K, Nakano S, Kigoshi T, Nakayama K, Uchida K. Receptor gene expression of glucagon-like peptide-1, but not glucose-dependent insulinotropic polypeptide, in rat nodose ganglion cells. Auton Neurosci. 2004;110:36-43.
-
(2004)
Auton Neurosci
, vol.110
, pp. 36-43
-
-
Nakagawa, A.1
Satake, H.2
Nakabayashi, H.3
Nishizawa, M.4
Furuya, K.5
Nakano, S.6
Kigoshi, T.7
Nakayama, K.8
Uchida, K.9
-
50
-
-
67649636449
-
Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms
-
18948395
-
Rüttimann EB, Arnold M, Hillebrand JJ, Geary N, Langhans W. Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms. Endocrinology. 2009;150:1174-81.
-
(2009)
Endocrinology
, vol.150
, pp. 1174-1181
-
-
Rüttimann, E.B.1
Arnold, M.2
Hillebrand, J.J.3
Geary, N.4
Langhans, W.5
-
51
-
-
18144381593
-
The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway
-
1:CAS:528:DC%2BD2MXjvVOiu7s%3D 15862798
-
Abbott CR, Monteiro M, Small CJ, Sajedi A, Smith KL, Parkinson JRC, Ghatei MA, Bloom SR. The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res. 2005;1044:127-31.
-
(2005)
Brain Res
, vol.1044
, pp. 127-131
-
-
Abbott, C.R.1
Monteiro, M.2
Small, C.J.3
Sajedi, A.4
Smith, K.L.5
Parkinson, J.R.C.6
Ghatei, M.A.7
Bloom, S.R.8
-
52
-
-
0034085701
-
Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats
-
1:STN:280:DC%2BD3czjtlKrtQ%3D%3D 10877194
-
Rodriquez de Fonseca F, Navarro M, Alvarez E, Roncero I, Chowen JA, Maestre O, Gómez R, Muñoz RM, Eng J, Blázquez E. Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats. Metabolism. 2000;49:709-17.
-
(2000)
Metabolism
, vol.49
, pp. 709-717
-
-
Rodriquez De Fonseca, F.1
Navarro, M.2
Alvarez, E.3
Roncero, I.4
Chowen, J.A.5
Maestre, O.6
Gómez, R.7
Muñoz, R.M.8
Eng, J.9
Blázquez, E.10
-
53
-
-
23844554610
-
Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice
-
1:CAS:528:DC%2BD2MXpsVehu7c%3D 15932924
-
Talsania T, Anini Y, Siu S, Drucker DJ, Brubaker PL. Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice. Endocrinology. 2005;146:3748-56.
-
(2005)
Endocrinology
, vol.146
, pp. 3748-3756
-
-
Talsania, T.1
Anini, Y.2
Siu, S.3
Drucker, D.J.4
Brubaker, P.L.5
-
54
-
-
19344375318
-
Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats
-
1:CAS:528:DC%2BD2MXlsVymsL0%3D 15718384
-
Chelikani PK, Haver AC, Reidelberger RD. Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats. Am J Physiol Regul Integr Comp Physiol. 2005;288:R1695-706.
-
(2005)
Am J Physiol Regul Integr Comp Physiol
, vol.288
, pp. R1695-R1706
-
-
Chelikani, P.K.1
Haver, A.C.2
Reidelberger, R.D.3
-
55
-
-
0034456212
-
Exendin-4 decelerates food intake, weight gain, and fat deposition in Zucker rats
-
1:CAS:528:DC%2BD3cXlt1Wnurc%3D 10830274
-
Szayna M, Doyle ME, Betkey JA, Holloway HW, Spencer RG, Greig NH, Egan JM. Exendin-4 decelerates food intake, weight gain, and fat deposition in Zucker rats. Endocrinology. 2000;141:1936-41.
-
(2000)
Endocrinology
, vol.141
, pp. 1936-1941
-
-
Szayna, M.1
Doyle, M.E.2
Betkey, J.A.3
Holloway, H.W.4
Spencer, R.G.5
Greig, N.H.6
Egan, J.M.7
-
56
-
-
84943648352
-
Exogenous glucagon-like peptide-1 acts in sites supplied by the cranial mesenteric artery to reduce meal size and prolong the intermeal interval in rats
-
26431682
-
Williams KE, Washington MC, Johnson-Rouse T, Johnson RE, Freeman C, Reed C, Heath J, Sayegh AI. Exogenous glucagon-like peptide-1 acts in sites supplied by the cranial mesenteric artery to reduce meal size and prolong the intermeal interval in rats. Appetite. 2015;96:254-9.
-
(2015)
Appetite
, vol.96
, pp. 254-259
-
-
Williams, K.E.1
Washington, M.C.2
Johnson-Rouse, T.3
Johnson, R.E.4
Freeman, C.5
Reed, C.6
Heath, J.7
Sayegh, A.I.8
-
57
-
-
0032005005
-
Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans
-
1:CAS:528:DyaK1cXosVagsg%3D%3D 9449682 508592
-
Flint A, Raben A, Astrup A, Holst JJ. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest. 1998;101:515-20.
-
(1998)
J Clin Invest
, vol.101
, pp. 515-520
-
-
Flint, A.1
Raben, A.2
Astrup, A.3
Holst, J.J.4
-
58
-
-
0031695395
-
Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men
-
9734726
-
Näslund E, Gutniak M, Skogar S, Rössner S, Hellström PM. Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men. Am J Clin Nutr. 1998;68:525-30.
-
(1998)
Am J Clin Nutr
, vol.68
, pp. 525-530
-
-
Näslund, E.1
Gutniak, M.2
Skogar, S.3
Rössner, S.4
Hellström, P.M.5
-
59
-
-
0033021677
-
Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men
-
10193877
-
Näslund E, Barkeling B, King N, Gutniak M, Blundell JE, Holst JJ, Rössner S, Hellström PM. Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men. Int J Obes Relat Metab Disord. 1999;23:304-11.
-
(1999)
Int J Obes Relat Metab Disord
, vol.23
, pp. 304-311
-
-
Näslund, E.1
Barkeling, B.2
King, N.3
Gutniak, M.4
Blundell, J.E.5
Holst, J.J.6
Rössner, S.7
Hellström, P.M.8
-
60
-
-
0032966882
-
Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2
-
1:CAS:528:DyaK1MXjsVWmu7k%3D 10233049
-
Gutzwiller JP, Drewe J, Göke B, Schmidt H, Rohrer B, Lareida J, Beglinger C. Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2. Am J Physiol. 1999;276(5 Pt 2):R1541-4.
-
(1999)
Am J Physiol
, vol.276
, Issue.5
, pp. R1541-R1544
-
-
Gutzwiller, J.P.1
Drewe, J.2
Göke, B.3
Schmidt, H.4
Rohrer, B.5
Lareida, J.6
Beglinger, C.7
-
61
-
-
0034951506
-
The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity
-
1:CAS:528:DC%2BD3MXkvVOhurk%3D 11439290
-
Flint A, Raben A, Ersbøll AK, Holst JJ, Astrup A. The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity. Int J Obes Relat Metab Disord. 2001;25:781-92.
-
(2001)
Int J Obes Relat Metab Disord
, vol.25
, pp. 781-792
-
-
Flint, A.1
Raben, A.2
Ersbøll, A.K.3
Holst, J.J.4
Astrup, A.5
-
62
-
-
0032976939
-
Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients
-
1:STN:280:DyaK1Mzhslaisg%3D%3D 10388979
-
Toft-Nielsen MB, Madsbad S, Holst JJ. Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients. Diabetes Care. 1999;22:1137-43.
-
(1999)
Diabetes Care
, vol.22
, pp. 1137-1143
-
-
Toft-Nielsen, M.B.1
Madsbad, S.2
Holst, J.J.3
-
63
-
-
79958851254
-
Food reward, hyperphagia, and obesity
-
1:CAS:528:DC%2BC3MXot1Grs7g%3D 21411768 3119156
-
Berthoud H-R, Lenard NR, Shin AC. Food reward, hyperphagia, and obesity. Am J Physiol Regul Integr Comp Physiol. 2011;300:R1266-77.
-
(2011)
Am J Physiol Regul Integr Comp Physiol
, vol.300
, pp. R1266-R1277
-
-
Berthoud, H.-R.1
Lenard, N.R.2
Shin, A.C.3
-
64
-
-
84864466120
-
Food and drug reward: Overlapping circuits in human obesity and addiction
-
1:STN:280:DC%2BC38zms12rtw%3D%3D 22016109
-
Volkow ND, Wang GJ, Fowler JS, Tomasi D, Baler R. Food and drug reward: overlapping circuits in human obesity and addiction. Curr Top Behav Neurosci. 2012;11:1-24.
-
(2012)
Curr Top Behav Neurosci
, vol.11
, pp. 1-24
-
-
Volkow, N.D.1
Wang, G.J.2
Fowler, J.S.3
Tomasi, D.4
Baler, R.5
-
65
-
-
84939563219
-
Brain reward-system activation in response to anticipation and consumption of palatable food is altered by glucagon-like peptide-1 receptor activation in humans
-
26094857
-
Van Bloemendaal L, Veltman DJ, Ten Kulve JS, Groot PFC, Ruhé HG, Barkhof F, Sloan JH, Diamant M, Ijzerman RG. Brain reward-system activation in response to anticipation and consumption of palatable food is altered by glucagon-like peptide-1 receptor activation in humans. Diabetes Obes Metab. 2015;17:878-86.
-
(2015)
Diabetes Obes Metab
, vol.17
, pp. 878-886
-
-
Van Bloemendaal, L.1
Veltman, D.J.2
Ten Kulve, J.S.3
Groot, P.F.C.4
Ruhé, H.G.5
Barkhof, F.6
Sloan, J.H.7
Diamant, M.8
Ijzerman, R.G.9
-
66
-
-
68649106375
-
Relation of obesity to consummatory and anticipatory food reward
-
1:CAS:528:DC%2BD1MXmvF2it7c%3D 19328819 2734415
-
Stice E, Spoor S, Ng J, Zald DH. Relation of obesity to consummatory and anticipatory food reward. Physiol Behav. 2009;97:551-60.
-
(2009)
Physiol Behav
, vol.97
, pp. 551-560
-
-
Stice, E.1
Spoor, S.2
Ng, J.3
Zald, D.H.4
-
67
-
-
56849092405
-
Relation of reward from food intake and anticipated food intake to obesity: A functional magnetic resonance imaging study
-
19025237 2681092
-
Stice E, Spoor S, Bohon C, Veldhuizen MG, Small DM. Relation of reward from food intake and anticipated food intake to obesity: a functional magnetic resonance imaging study. J Abnorm Psychol. 2008;117:924-35.
-
(2008)
J Abnorm Psychol
, vol.117
, pp. 924-935
-
-
Stice, E.1
Spoor, S.2
Bohon, C.3
Veldhuizen, M.G.4
Small, D.M.5
-
68
-
-
0041422625
-
Feeding-induced dopamine release in dorsal striatum correlates with meal pleasantness ratings in healthy human volunteers
-
12948725
-
Small DM, Jones-Gotman M, Dagher A. Feeding-induced dopamine release in dorsal striatum correlates with meal pleasantness ratings in healthy human volunteers. Neuroimage. 2003;19:1709-15.
-
(2003)
Neuroimage
, vol.19
, pp. 1709-1715
-
-
Small, D.M.1
Jones-Gotman, M.2
Dagher, A.3
-
69
-
-
84942816946
-
Emotional eating is associated with increased brain responses to food-cues and reduced sensitivity to GLP-1 receptor activation
-
26331843
-
Van Bloemendaal L, Veltman DJ, ten Kulve JS, Drent ML, Barkhof F, Diamant M, IJzerman RG. Emotional eating is associated with increased brain responses to food-cues and reduced sensitivity to GLP-1 receptor activation. Obesity. 2015;23:2075-82.
-
(2015)
Obesity
, vol.23
, pp. 2075-2082
-
-
Van Bloemendaal, L.1
Veltman, D.J.2
Ten Kulve, J.S.3
Drent, M.L.4
Barkhof, F.5
Diamant, M.6
Ijzerman, R.G.7
-
70
-
-
84910070505
-
GLP-1 Receptor activation modulates appetite- and reward-related brain areas in humans
-
25071023
-
Van Bloemendaal L, IJzerman RG, ten Kulve JS, Barkhof F, Konrad RJ, Drent ML, Veltman DJ, Diamant M. GLP-1 Receptor activation modulates appetite- and reward-related brain areas in humans. Diabetes. 2014;63:4186-96.
-
(2014)
Diabetes
, vol.63
, pp. 4186-4196
-
-
Van Bloemendaal, L.1
Ijzerman, R.G.2
Ten Kulve, J.S.3
Barkhof, F.4
Konrad, R.J.5
Drent, M.L.6
Veltman, D.J.7
Diamant, M.8
-
71
-
-
80054035293
-
Glucagon-like peptide 1 receptors in nucleus accumbens affect food intake
-
1:CAS:528:DC%2BC3MXhtlCgtr%2FF 21994361 3328130
-
Dossat AM, Lilly N, Kay K, Williams DL. Glucagon-like peptide 1 receptors in nucleus accumbens affect food intake. J Neurosci. 2011;31:14453-7.
-
(2011)
J Neurosci
, vol.31
, pp. 14453-14457
-
-
Dossat, A.M.1
Lilly, N.2
Kay, K.3
Williams, D.L.4
-
72
-
-
84907651898
-
Hindbrain nucleus tractus solitarius glucagon-like peptide-1 receptor signaling reduces appetitive and motivational aspects of feeding
-
1:CAS:528:DC%2BC2cXhsFanurfP 24944243 4137150
-
Alhadeff AL, Grill HJ. Hindbrain nucleus tractus solitarius glucagon-like peptide-1 receptor signaling reduces appetitive and motivational aspects of feeding. Am J Physiol Regul Integr Comp Physiol. 2014;307:R465-70.
-
(2014)
Am J Physiol Regul Integr Comp Physiol
, vol.307
, pp. R465-R470
-
-
Alhadeff, A.L.1
Grill, H.J.2
-
73
-
-
84880459479
-
The glucagon-like peptide 1 analogue, exendin-4, attenuates the rewarding properties of psychostimulant drugs in mice
-
e69010 1:CAS:528:DC%2BC3sXht1SgsrvM 23874851 3712951
-
Egecioglu E, Engel JA, Jerlhag E. The glucagon-like peptide 1 analogue, exendin-4, attenuates the rewarding properties of psychostimulant drugs in mice. PLoS One. 2013;8, e69010.
-
(2013)
PLoS One
, vol.8
-
-
Egecioglu, E.1
Engel, J.A.2
Jerlhag, E.3
-
74
-
-
84946499280
-
Endogenous GLP-1 mediates postprandial reductions in activation in central reward and satiety areas in patients with type 2 diabetes
-
Ten Kulve JS, Veltman DJ, van Bloemendaal L, Barkhof F, Deacon CF, Holst JJ, Konrad RJ, Sloan JH, Drent ML, Diamant M, IJzerman RG. Endogenous GLP-1 mediates postprandial reductions in activation in central reward and satiety areas in patients with type 2 diabetes. Diabetologia. 2015.
-
(2015)
Diabetologia
-
-
Ten Kulve, J.S.1
Veltman, D.J.2
Van Bloemendaal, L.3
Barkhof, F.4
Deacon, C.F.5
Holst, J.J.6
Konrad, R.J.7
Sloan, J.H.8
Drent, M.L.9
Diamant, M.10
Ijzerman, R.G.11
-
75
-
-
84888860281
-
The food intake-suppressive effects of glucagon-like peptide-1 receptor signaling in the ventral tegmental area are mediated by AMPA/kainate receptors
-
1:CAS:528:DC%2BC2cXksVShtg%3D%3D 24105414 3882373
-
Mietlicki-Baase EG, Ortinski PI, Rupprecht LE, Olivos DR, Alhadeff AL, Pierce RC, Hayes MR. The food intake-suppressive effects of glucagon-like peptide-1 receptor signaling in the ventral tegmental area are mediated by AMPA/kainate receptors. Am J Physiol Endocrinol Metab. 2013;305:E1367-74.
-
(2013)
Am J Physiol Endocrinol Metab
, vol.305
, pp. E1367-E1374
-
-
Mietlicki-Baase, E.G.1
Ortinski, P.I.2
Rupprecht, L.E.3
Olivos, D.R.4
Alhadeff, A.L.5
Pierce, R.C.6
Hayes, M.R.7
-
76
-
-
84938553210
-
Endogenous Glucagon-like Peptide-1 Suppresses High-Fat Food Intake by Reducing Synaptic Drive onto Mesolimbic Dopamine Neurons
-
26212334 4860285
-
Wang X-F, Liu J-J, Xia J, Liu J, Mirabella V, Pang Correspondence ZP. Endogenous Glucagon-like Peptide-1 Suppresses High-Fat Food Intake by Reducing Synaptic Drive onto Mesolimbic Dopamine Neurons. Cell Reports. 2015;12:726-33.
-
(2015)
Cell Reports
, vol.12
, pp. 726-733
-
-
Wang, X.-F.1
Liu, J.-J.2
Xia, J.3
Liu, J.4
Mirabella, V.5
Pang Correspondence, Z.P.6
-
77
-
-
84917732297
-
Dopamine signaling in the amygdala, increased by food ingestion and GLP-1, regulates feeding behavior
-
1:CAS:528:DC%2BC2cXkt1Srsbk%3D 24560840
-
Anderberg RH, Anefors C, Bergquist F, Nissbrandt H, Skibicka KP. Dopamine signaling in the amygdala, increased by food ingestion and GLP-1, regulates feeding behavior. Physiol Behav. 2014;136:135-44.
-
(2014)
Physiol Behav
, vol.136
, pp. 135-144
-
-
Anderberg, R.H.1
Anefors, C.2
Bergquist, F.3
Nissbrandt, H.4
Skibicka, K.P.5
-
78
-
-
0027480005
-
Hypersecretion of Truncated Glucagon-like Peptide-1 and Gastric Inhibitory Polypeptide in Obese Patients
-
1:STN:280:DyaK3s7mvF2isQ%3D%3D 8435987
-
Fukase N, Igarashi M, Takahashi H, Manaka H, Yamatani K, Daimon M, Tominaga M, Sasaki H. Hypersecretion of Truncated Glucagon-like Peptide-1 and Gastric Inhibitory Polypeptide in Obese Patients. Diabet Med. 1993;10:44-9.
-
(1993)
Diabet Med
, vol.10
, pp. 44-49
-
-
Fukase, N.1
Igarashi, M.2
Takahashi, H.3
Manaka, H.4
Yamatani, K.5
Daimon, M.6
Tominaga, M.7
Sasaki, H.8
-
79
-
-
0028879785
-
Response of truncated glucagon-like peptide-1 and gastric inhibitory polypeptide to glucose ingestion in non-insulin dependent diabetes mellitus
-
1:STN:280:DyaK287js1GjtQ%3D%3D 8590785
-
Fukase N, Manaka H, Sugiyama K, Takahashi H, Igarashi M, Daimon M, Yamatani K, Tominaga M, Sasaki H. Response of truncated glucagon-like peptide-1 and gastric inhibitory polypeptide to glucose ingestion in non-insulin dependent diabetes mellitus. Acta Diabetol. 1995;32:165-9.
-
(1995)
Acta Diabetol
, vol.32
, pp. 165-169
-
-
Fukase, N.1
Manaka, H.2
Sugiyama, K.3
Takahashi, H.4
Igarashi, M.5
Daimon, M.6
Yamatani, K.7
Tominaga, M.8
Sasaki, H.9
-
80
-
-
0030845083
-
Reduced gastric inhibitory polypeptide but normal glucagon-like peptide 1 response to oral glucose in postmenopausal women with impaired glucose tolerance
-
1:CAS:528:DyaK2sXls12gtr0%3D 9272099
-
Ahren B, Larsson H, Holst J. Reduced gastric inhibitory polypeptide but normal glucagon-like peptide 1 response to oral glucose in postmenopausal women with impaired glucose tolerance. Eur J Endocrinol. 1997;137:127-31.
-
(1997)
Eur J Endocrinol
, vol.137
, pp. 127-131
-
-
Ahren, B.1
Larsson, H.2
Holst, J.3
-
81
-
-
12144289077
-
Glucagon-like peptide 1 (GLP-1) secretion and plasma dipeptidyl peptidase IV (DPP-IV) activity in morbidly obese patients undergoing biliopancreatic diversion
-
1:CAS:528:DC%2BD2cXislCjt7Y%3D 15002062
-
Lugari R, Dei Cas A, Ugolotti D, Barilli AL, Camellini C, Ganzerla GC, Luciani A, Salerni B, Mittenperger F, Nodari S, Gnudi A, Zandomeneghi R. Glucagon-like peptide 1 (GLP-1) secretion and plasma dipeptidyl peptidase IV (DPP-IV) activity in morbidly obese patients undergoing biliopancreatic diversion. Horm Metab Res. 2004;36:111-5.
-
(2004)
Horm Metab Res
, vol.36
, pp. 111-115
-
-
Lugari, R.1
Dei Cas, A.2
Ugolotti, D.3
Barilli, A.L.4
Camellini, C.5
Ganzerla, G.C.6
Luciani, A.7
Salerni, B.8
Mittenperger, F.9
Nodari, S.10
Gnudi, A.11
Zandomeneghi, R.12
-
82
-
-
0034880691
-
Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes
-
1:CAS:528:DC%2BD3MXlvFeku70%3D 11502823
-
Toft-Nielsen MB, Madsbad S, Holst JJ. Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes. J Clin Endocrinol Metab. 2001;86:3853-60.
-
(2001)
J Clin Endocrinol Metab
, vol.86
, pp. 3853-3860
-
-
Toft-Nielsen, M.B.1
Madsbad, S.2
Holst, J.J.3
-
83
-
-
0034880655
-
Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients
-
1:CAS:528:DC%2BD3MXlvFektLc%3D 11502801
-
Toft-Nielsen MB, Damholt MB, Madsbad S, Hilsted LM, Hughes TE, Michelsen BK, Holst JJ. Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients. J Clin Endocrinol Metab. 2001;86:3717-23.
-
(2001)
J Clin Endocrinol Metab
, vol.86
, pp. 3717-3723
-
-
Toft-Nielsen, M.B.1
Damholt, M.B.2
Madsbad, S.3
Hilsted, L.M.4
Hughes, T.E.5
Michelsen, B.K.6
Holst, J.J.7
-
84
-
-
0032966882
-
Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2
-
1:CAS:528:DyaK1MXjsVWmu7k%3D
-
Gutzwiller J-P, Drewe J, Goke B, Schmidt H, Rohrer B, Lareida J, Beglinger C. Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2. Am J Physiol Regul Integr Comp Physiol. 1999;276:R1541-1544.
-
(1999)
Am J Physiol Regul Integr Comp Physiol
, vol.276
, pp. R1541-R1544
-
-
Gutzwiller, J.-P.1
Drewe, J.2
Goke, B.3
Schmidt, H.4
Rohrer, B.5
Lareida, J.6
Beglinger, C.7
-
85
-
-
84930791550
-
β-Cell Sensitivity to GLP-1 in Healthy Humans Is Variable and Proportional to Insulin Sensitivity
-
1:CAS:528:DC%2BC2MXhtVOqsr7P 25825945 4454808
-
Aulinger BA, Vahl TP, Wilson-Pérez HE, Prigeon RL, D'Alessio DA. β-Cell Sensitivity to GLP-1 in Healthy Humans Is Variable and Proportional to Insulin Sensitivity. J Clin Endocrinol Metab. 2015;100:2489-96.
-
(2015)
J Clin Endocrinol Metab
, vol.100
, pp. 2489-2496
-
-
Aulinger, B.A.1
Vahl, T.P.2
Wilson-Pérez, H.E.3
Prigeon, R.L.4
D'Alessio, D.A.5
-
86
-
-
0027391607
-
Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus
-
1:STN:280:DyaK3s7jvFaguw%3D%3D 8423228 330027
-
Nauck MA, Heimesaat MM, Orskov C, Holst JJ, Ebert R, Creutzfeldt W. Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J Clin Invest. 1993;91:301-7.
-
(1993)
J Clin Invest
, vol.91
, pp. 301-307
-
-
Nauck, M.A.1
Heimesaat, M.M.2
Orskov, C.3
Holst, J.J.4
Ebert, R.5
Creutzfeldt, W.6
-
88
-
-
33846006173
-
The incretin system: Glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
-
1:CAS:528:DC%2BD28XhtF2gurjM 17098089
-
Drucker DJ, Nauck MA. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet. 2006;368:1696-705.
-
(2006)
Lancet
, vol.368
, pp. 1696-1705
-
-
Drucker, D.J.1
Nauck, M.A.2
-
89
-
-
84938932103
-
A clinical review of GLP-1 receptor agonists: Efficacy and safety in diabetes and beyond
-
26213556 4509428
-
Prasad-Reddy L, Isaacs D. A clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyond. Drugs Context. 2015;4:212283.
-
(2015)
Drugs Context
, vol.4
, pp. 212283
-
-
Prasad-Reddy, L.1
Isaacs, D.2
-
90
-
-
84929963055
-
-
U.S. Food and Drug Administration
-
U.S. Food and Drug Administration. FDA approves weight-management drug Saxenda. 2014. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm427913.htm.
-
(2014)
FDA Approves Weight-management Drug Saxenda
-
-
-
91
-
-
84906711873
-
Beyond metformin: Safety considerations in the decision-making process for selecting a second medication for type 2 diabetes management: Reflections from a diabetes care editors' expert forum
-
1:CAS:528:DC%2BC2cXhslCqur%2FF 25147257
-
Cefalu WT, Buse JB, Del Prato S, Home PD, LeRoith D, Nauck MA, Raz I, Rosenstock J, Riddle MC. Beyond metformin: safety considerations in the decision-making process for selecting a second medication for type 2 diabetes management: reflections from a diabetes care editors' expert forum. Diabetes Care. 2014;37:2647-59.
-
(2014)
Diabetes Care
, vol.37
, pp. 2647-2659
-
-
Cefalu, W.T.1
Buse, J.B.2
Del Prato, S.3
Home, P.D.4
LeRoith, D.5
Nauck, M.A.6
Raz, I.7
Rosenstock, J.8
Riddle, M.C.9
-
92
-
-
30144444692
-
Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters
-
16371744 1449984
-
Le Roux CW, Aylwin SJB, Batterham RL, Borg CM, Coyle F, Prasad V, Shurey S, Ghatei MA, Patel AG, Bloom SR. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg. 2006;243:108-14.
-
(2006)
Ann Surg
, vol.243
, pp. 108-114
-
-
Le Roux, C.W.1
Aylwin, S.J.B.2
Batterham, R.L.3
Borg, C.M.4
Coyle, F.5
Prasad, V.6
Shurey, S.7
Ghatei, M.A.8
Patel, A.G.9
Bloom, S.R.10
-
93
-
-
32944470975
-
Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety
-
1:CAS:528:DC%2BD28XisF2gsrs%3D 16392104
-
Borg CM, le Roux CW, Ghatei MA, Bloom SR, Patel AG, Aylwin SJB. Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety. Br J Surg. 2006;93:210-5.
-
(2006)
Br J Surg
, vol.93
, pp. 210-215
-
-
Borg, C.M.1
Le Roux, C.W.2
Ghatei, M.A.3
Bloom, S.R.4
Patel, A.G.5
Aylwin, S.J.B.6
-
94
-
-
80053653242
-
Gastric bypass reduces fat intake and preference
-
21734019 3197335
-
Le Roux CW, Bueter M, Theis N, Werling M, Ashrafian H, Löwenstein C, Athanasiou T, Bloom SR, Spector AC, Olbers T, Lutz TA. Gastric bypass reduces fat intake and preference. Am J Physiol Regul Integr Comp Physiol. 2011;301:R1057-66.
-
(2011)
Am J Physiol Regul Integr Comp Physiol
, vol.301
, pp. R1057-R1066
-
-
Le Roux, C.W.1
Bueter, M.2
Theis, N.3
Werling, M.4
Ashrafian, H.5
Löwenstein, C.6
Athanasiou, T.7
Bloom, S.R.8
Spector, A.C.9
Olbers, T.10
Lutz, T.A.11
-
95
-
-
0021946950
-
Macronutrients have different metabolic effects in nondiabetics and diabetics
-
1:STN:280:DyaL2Mzgtl2ltQ%3D%3D 3898804
-
Simpson RW, McDonald J, Wahlqvist ML, Atley L, Outch K. Macronutrients have different metabolic effects in nondiabetics and diabetics. Am J Clin Nutr. 1985;42:449-53.
-
(1985)
Am J Clin Nutr
, vol.42
, pp. 449-453
-
-
Simpson, R.W.1
McDonald, J.2
Wahlqvist, M.L.3
Atley, L.4
Outch, K.5
-
96
-
-
0021678763
-
Effect of source of dietary carbohydrate on plasma glucose, insulin, and gastric inhibitory polypeptide responses to test meals in subjects with noninsulin-dependent diabetes mellitus
-
1:CAS:528:DyaL2MXkvVKq 6388305
-
Coulston AM, Hollenbeck CB, Liu GC, Williams RA, Starich GH, Mazzaferri EL, Reaven GM. Effect of source of dietary carbohydrate on plasma glucose, insulin, and gastric inhibitory polypeptide responses to test meals in subjects with noninsulin-dependent diabetes mellitus. Am J Clin Nutr. 1984;40:965-70.
-
(1984)
Am J Clin Nutr
, vol.40
, pp. 965-970
-
-
Coulston, A.M.1
Hollenbeck, C.B.2
Liu, G.C.3
Williams, R.A.4
Starich, G.H.5
Mazzaferri, E.L.6
Reaven, G.M.7
-
97
-
-
84884356128
-
A quick look at biochemistry: Carbohydrate metabolism
-
1:CAS:528:DC%2BC3sXht1GgtLnJ 23680095
-
Dashty M. A quick look at biochemistry: carbohydrate metabolism. Clin Biochem. 2013;46:1339-52.
-
(2013)
Clin Biochem
, vol.46
, pp. 1339-1352
-
-
Dashty, M.1
-
98
-
-
72249113386
-
Activation of sodium-glucose cotransporter 1 ameliorates hyperglycemia by mediating incretin secretion in mice
-
1:CAS:528:DC%2BD1MXhsFOgsbnF 19808907
-
Moriya R, Shirakura T, Ito J, Mashiko S, Seo T. Activation of sodium-glucose cotransporter 1 ameliorates hyperglycemia by mediating incretin secretion in mice. Am J Physiol Endocrinol Metab. 2009;297:E1358-65.
-
(2009)
Am J Physiol Endocrinol Metab
, vol.297
, pp. E1358-E1365
-
-
Moriya, R.1
Shirakura, T.2
Ito, J.3
Mashiko, S.4
Seo, T.5
-
99
-
-
84555186977
-
Na(+)-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion
-
1:CAS:528:DC%2BC38XltFSnsrk%3D 22124465
-
Gorboulev V, Schürmann A, Vallon V, Kipp H, Jaschke A, Klessen D, Friedrich A, Scherneck S, Rieg T, Cunard R, Veyhl-Wichmann M, Srinivasan A, Balen D, Breljak D, Rexhepaj R, Parker HE, Gribble FM, Reimann F, Lang F, Wiese S, Sabolic I, Sendtner M, Koepsell H. Na(+)-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion. Diabetes. 2012;61:187-96.
-
(2012)
Diabetes
, vol.61
, pp. 187-196
-
-
Gorboulev, V.1
Schürmann, A.2
Vallon, V.3
Kipp, H.4
Jaschke, A.5
Klessen, D.6
Friedrich, A.7
Scherneck, S.8
Rieg, T.9
Cunard, R.10
Veyhl-Wichmann, M.11
Srinivasan, A.12
Balen, D.13
Breljak, D.14
Rexhepaj, R.15
Parker, H.E.16
Gribble, F.M.17
Reimann, F.18
Lang, F.19
Wiese, S.20
Sabolic, I.21
Sendtner, M.22
Koepsell, H.23
more..
-
100
-
-
84876519168
-
LX4211 increases serum glucagon-like peptide 1 and peptide YY levels by reducing sodium/glucose cotransporter 1 (SGLT1)-mediated absorption of intestinal glucose
-
1:CAS:528:DC%2BC3sXntVCgsbw%3D 23487174
-
Powell DR, Smith M, Greer J, Harris A, Zhao S, DaCosta C, Mseeh F, Shadoan MK, Sands A, Zambrowicz B, Ding Z-M. LX4211 increases serum glucagon-like peptide 1 and peptide YY levels by reducing sodium/glucose cotransporter 1 (SGLT1)-mediated absorption of intestinal glucose. J Pharmacol Exp Ther. 2013;345:250-9.
-
(2013)
J Pharmacol Exp Ther
, vol.345
, pp. 250-259
-
-
Powell, D.R.1
Smith, M.2
Greer, J.3
Harris, A.4
Zhao, S.5
DaCosta, C.6
Mseeh, F.7
Shadoan, M.K.8
Sands, A.9
Zambrowicz, B.10
Ding, Z.-M.11
-
101
-
-
84882831390
-
Effects of LX4211, a dual sodium-dependent glucose cotransporters 1 and 2 inhibitor, on postprandial glucose, insulin, glucagon-like peptide 1, and peptide tyrosine tyrosine in a dose-timing study in healthy subjects
-
1:CAS:528:DC%2BC3sXht1Wrs7rE 23911260 e8
-
Zambrowicz B, Ogbaa I, Frazier K, Banks P, Turnage A, Freiman J, Boehm KA, Ruff D, Powell D, Sands A. Effects of LX4211, a dual sodium-dependent glucose cotransporters 1 and 2 inhibitor, on postprandial glucose, insulin, glucagon-like peptide 1, and peptide tyrosine tyrosine in a dose-timing study in healthy subjects. Clin Ther. 2013;35:1162-73. e8.
-
(2013)
Clin Ther
, vol.35
, pp. 1162-1173
-
-
Zambrowicz, B.1
Ogbaa, I.2
Frazier, K.3
Banks, P.4
Turnage, A.5
Freiman, J.6
Boehm, K.A.7
Ruff, D.8
Powell, D.9
Sands, A.10
-
102
-
-
84874977086
-
Effects of LX4211, a dual SGLT1/SGLT2 inhibitor, plus sitagliptin on postprandial active GLP-1 and glycemic control in type 2 diabetes
-
1:CAS:528:DC%2BC3sXivFyksrc%3D 23433601 e7
-
Zambrowicz B, Ding Z-M, Ogbaa I, Frazier K, Banks P, Turnage A, Freiman J, Smith M, Ruff D, Sands A, Powell D. Effects of LX4211, a dual SGLT1/SGLT2 inhibitor, plus sitagliptin on postprandial active GLP-1 and glycemic control in type 2 diabetes. Clin Ther. 2013;35:273-85. e7.
-
(2013)
Clin Ther
, vol.35
, pp. 273-285
-
-
Zambrowicz, B.1
Ding, Z.-M.2
Ogbaa, I.3
Frazier, K.4
Banks, P.5
Turnage, A.6
Freiman, J.7
Smith, M.8
Ruff, D.9
Sands, A.10
Powell, D.11
-
103
-
-
41049090425
-
Expression of the short-chain fatty acid receptor, GPR43, in the human colon
-
1:CAS:528:DC%2BD1cXjsFWrsbc%3D 17899402
-
Karaki S-I, Tazoe H, Hayashi H, Kashiwabara H, Tooyama K, Suzuki Y, Kuwahara A. Expression of the short-chain fatty acid receptor, GPR43, in the human colon. J Mol Histol. 2008;39:135-42.
-
(2008)
J Mol Histol
, vol.39
, pp. 135-142
-
-
Karaki, S.-I.1
Tazoe, H.2
Hayashi, H.3
Kashiwabara, H.4
Tooyama, K.5
Suzuki, Y.6
Kuwahara, A.7
-
104
-
-
70149102106
-
Expression of short-chain fatty acid receptor GPR41 in the human colon
-
1:CAS:528:DC%2BD1MXotlGjtb8%3D 19574715
-
Tazoe H, Otomo Y, Karaki S-I, Kato I, Fukami Y, Terasaki M, Kuwahara A. Expression of short-chain fatty acid receptor GPR41 in the human colon. Biomed Res. 2009;30:149-56.
-
(2009)
Biomed Res
, vol.30
, pp. 149-156
-
-
Tazoe, H.1
Otomo, Y.2
Karaki, S.-I.3
Kato, I.4
Fukami, Y.5
Terasaki, M.6
Kuwahara, A.7
-
105
-
-
0038491435
-
Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation
-
12711604
-
Le Poul E, Loison C, Struyf S, Springael J-Y, Lannoy V, Decobecq M-E, Brezillon S, Dupriez V, Vassart G, Van Damme J, Parmentier M, Detheux M. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem. 2003;278:25481-9.
-
(2003)
J Biol Chem
, vol.278
, pp. 25481-25489
-
-
Le Poul, E.1
Loison, C.2
Struyf, S.3
Springael, J.-Y.4
Lannoy, V.5
Decobecq, M.-E.6
Brezillon, S.7
Dupriez, V.8
Vassart, G.9
Van Damme, J.10
Parmentier, M.11
Detheux, M.12
-
106
-
-
0038363378
-
The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids
-
1:CAS:528:DC%2BD3sXit1Kgsbc%3D 12496283
-
Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, Muir AI, Wigglesworth MJ, Kinghorn I, Fraser NJ, Pike NB, Strum JC, Steplewski KM, Murdock PR, Holder JC, Marshall FH, Szekeres PG, Wilson S, Ignar DM, Foord SM, Wise A, Dowell SJ. The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem. 2003;278:11312-9.
-
(2003)
J Biol Chem
, vol.278
, pp. 11312-11319
-
-
Brown, A.J.1
Goldsworthy, S.M.2
Barnes, A.A.3
Eilert, M.M.4
Tcheang, L.5
Daniels, D.6
Muir, A.I.7
Wigglesworth, M.J.8
Kinghorn, I.9
Fraser, N.J.10
Pike, N.B.11
Strum, J.C.12
Steplewski, K.M.13
Murdock, P.R.14
Holder, J.C.15
Marshall, F.H.16
Szekeres, P.G.17
Wilson, S.18
Ignar, D.M.19
Foord, S.M.20
Wise, A.21
Dowell, S.J.22
more..
-
107
-
-
0037453280
-
Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids
-
1:CAS:528:DC%2BD3sXis12gsbc%3D 12684041
-
Nilsson NE, Kotarsky K, Owman C, Olde B. Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids. Biochem Biophys Res Commun. 2003;303:1047-52.
-
(2003)
Biochem Biophys Res Commun
, vol.303
, pp. 1047-1052
-
-
Nilsson, N.E.1
Kotarsky, K.2
Owman, C.3
Olde, B.4
-
108
-
-
84884693129
-
GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes
-
23885020
-
Nøhr MK, Pedersen MH, Gille A, Egerod KL, Engelstoft MS, Husted AS, Sichlau RM, Grunddal KV, Poulsen SS, Han S, Jones RM, Offermanns S, Schwartz TW. GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes. Endocrinology. 2013;154:3552-64.
-
(2013)
Endocrinology
, vol.154
, pp. 3552-3564
-
-
Nøhr, M.K.1
Pedersen, M.H.2
Gille, A.3
Egerod, K.L.4
Engelstoft, M.S.5
Husted, A.S.6
Sichlau, R.M.7
Grunddal, K.V.8
Poulsen, S.S.9
Han, S.10
Jones, R.M.11
Offermanns, S.12
Schwartz, T.W.13
-
109
-
-
84921890499
-
Short-chain fatty acid sensing in rat duodenum
-
1:CAS:528:DC%2BC2MXhslagtL8%3D 25433076 4324707
-
Akiba Y, Inoue T, Kaji I, Higashiyama M, Narimatsu K, Iwamoto K, Watanabe M, Guth PH, Engel E, Kuwahara A, Kaunitz JD. Short-chain fatty acid sensing in rat duodenum. J Physiol. 2015;593:585-99.
-
(2015)
J Physiol
, vol.593
, pp. 585-599
-
-
Akiba, Y.1
Inoue, T.2
Kaji, I.3
Higashiyama, M.4
Narimatsu, K.5
Iwamoto, K.6
Watanabe, M.7
Guth, P.H.8
Engel, E.9
Kuwahara, A.10
Kaunitz, J.D.11
-
110
-
-
52749098923
-
Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion
-
1:CAS:528:DC%2BD1cXhtFSrtrvP 18519800 2518478
-
Edfalk S, Steneberg P, Edlund H. Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion. Diabetes. 2008;57:2280-7.
-
(2008)
Diabetes
, vol.57
, pp. 2280-2287
-
-
Edfalk, S.1
Steneberg, P.2
Edlund, H.3
-
111
-
-
84920736359
-
GPR40 (FFAR1) - Combined Gs and Gq signaling in vitro is associated with robust incretin secretagogue action ex vivo and in vivo
-
1:CAS:528:DC%2BC2cXhvVCku7bN 25685685
-
Hauge M, Vestmar MA, Husted AS, Ekberg JP, Wright MJ, Di Salvo J, Weinglass AB, Engelstoft MS, Madsen AN, Lückmann M, Miller MW, Trujillo ME, Frimurer TM, Holst B, Howard AD, Schwartz TW. GPR40 (FFAR1) - Combined Gs and Gq signaling in vitro is associated with robust incretin secretagogue action ex vivo and in vivo. Mol Metab. 2015;4:3-14.
-
(2015)
Mol Metab
, vol.4
, pp. 3-14
-
-
Hauge, M.1
Vestmar, M.A.2
Husted, A.S.3
Ekberg, J.P.4
Wright, M.J.5
Di Salvo, J.6
Weinglass, A.B.7
Engelstoft, M.S.8
Madsen, A.N.9
Lückmann, M.10
Miller, M.W.11
Trujillo, M.E.12
Frimurer, T.M.13
Holst, B.14
Howard, A.D.15
Schwartz, T.W.16
-
112
-
-
0242552061
-
Regulation of Glucagon-Like Peptide-1 Receptor and Calcium-Sensing Receptor Signaling by l-Histidine
-
Leech CA, Habener JF. Regulation of Glucagon-Like Peptide-1 Receptor and Calcium-Sensing Receptor Signaling by l-Histidine. Endocrinology. 2013;144:4851-8.
-
(2013)
Endocrinology
, vol.144
, pp. 4851-4858
-
-
Leech, C.A.1
Habener, J.F.2
-
113
-
-
84862560443
-
The regulation of K- and L-cell activity by GLUT2 and the calcium-sensing receptor CasR in rat small intestine
-
1:CAS:528:DC%2BC38XhtFehtLjE 22495587 3448156
-
Mace OJ, Schindler M, Patel S. The regulation of K- and L-cell activity by GLUT2 and the calcium-sensing receptor CasR in rat small intestine. J Physiol. 2012;590(Pt 12):2917-36.
-
(2012)
J Physiol
, vol.590
, pp. 2917-2936
-
-
Mace, O.J.1
Schindler, M.2
Patel, S.3
-
114
-
-
84888000680
-
Oligopeptides stimulate glucagon-like peptide-1 secretion in mice through proton-coupled uptake and the calcium-sensing receptor
-
1:CAS:528:DC%2BC3sXhsVOns7%2FN 24045836 3825574
-
Diakogiannaki E, Pais R, Tolhurst G, Parker HE, Horscroft J, Rauscher B, Zietek T, Daniel H, Gribble FM, Reimann F. Oligopeptides stimulate glucagon-like peptide-1 secretion in mice through proton-coupled uptake and the calcium-sensing receptor. Diabetologia. 2013;56:2688-96.
-
(2013)
Diabetologia
, vol.56
, pp. 2688-2696
-
-
Diakogiannaki, E.1
Pais, R.2
Tolhurst, G.3
Parker, H.E.4
Horscroft, J.5
Rauscher, B.6
Zietek, T.7
Daniel, H.8
Gribble, F.M.9
Reimann, F.10
-
115
-
-
84885604147
-
Endogenous PYY and GLP-1 mediate l-glutamine responses in intestinal mucosa
-
1:CAS:528:DC%2BC3sXhs1SlurbK 23992397 3902494
-
Joshi S, Tough IR, Cox HM. Endogenous PYY and GLP-1 mediate l-glutamine responses in intestinal mucosa. Br J Pharmacol. 2013;170:1092-101.
-
(2013)
Br J Pharmacol
, vol.170
, pp. 1092-1101
-
-
Joshi, S.1
Tough, I.R.2
Cox, H.M.3
-
116
-
-
84960808046
-
Signalling pathways involved in the detection of peptones by murine small intestinal enteroendocrine L-cells
-
26215048
-
Pais R, Gribble FM, Reimann F. Signalling pathways involved in the detection of peptones by murine small intestinal enteroendocrine L-cells. Peptides. 2015;77:9-15.
-
(2015)
Peptides
, vol.77
, pp. 9-15
-
-
Pais, R.1
Gribble, F.M.2
Reimann, F.3
-
117
-
-
0141532690
-
A novel glucose-sensing mechanism contributing to Glucagon-Like Peptide-1 Secretion from the GLUTag cell line
-
1:CAS:528:DC%2BD3sXjsFGhtbo%3D 12716745
-
Gribble FM, Williams L, Simpson AK, Reimann F. A novel glucose-sensing mechanism contributing to Glucagon-Like Peptide-1 Secretion from the GLUTag cell line. Diabetes. 2003;52:1147-54.
-
(2003)
Diabetes
, vol.52
, pp. 1147-1154
-
-
Gribble, F.M.1
Williams, L.2
Simpson, A.K.3
Reimann, F.4
-
118
-
-
0023856812
-
Short-chain fatty acid production from mono- and disaccharides in a fecal incubation system: Implications for colonic fermentation of dietary fiber in humans
-
APRIL 1:CAS:528:DyaL1cXit1Sktro%3D 2832567
-
Mortensen PB, Holtug K, Rasmussen HS. Short-chain fatty acid production from mono- and disaccharides in a fecal incubation system: implications for colonic fermentation of dietary fiber in humans. J Nutr. 1988;118(April):321-5.
-
(1988)
J Nutr
, vol.118
, pp. 321-325
-
-
Mortensen, P.B.1
Holtug, K.2
Rasmussen, H.S.3
-
119
-
-
0025852087
-
Fermentability of various fiber sources by human fecal bacteria in vitro
-
1:STN:280:DyaK3M3ktFSntA%3D%3D 1852091
-
Titgemeyer E, Bourquin L, Fahey GCJ, Garleb K. Fermentability of various fiber sources by human fecal bacteria in vitro. Am J Clin Nutr. 1991;53:1418-24.
-
(1991)
Am J Clin Nutr
, vol.53
, pp. 1418-1424
-
-
Titgemeyer, E.1
Bourquin, L.2
Fahey, G.C.J.3
Garleb, K.4
-
120
-
-
0029886692
-
Fermentation of various dietary fiber sources by human fecal bacteria
-
Bourquin LD, Titgemeyer EC, Fahey GC. Fermentation of various dietary fiber sources by human fecal bacteria. Nutr Res. 1996;16:1119-31.
-
(1996)
Nutr Res
, vol.16
, pp. 1119-1131
-
-
Bourquin, L.D.1
Titgemeyer, E.C.2
Fahey, G.C.3
-
121
-
-
0034177384
-
Effect of Oligosaccharides and fibre substitutes on short-chain fatty acid production by Human Faecal Microflora
-
Velázquez M, Davies C, Marett R, Slavin JL, Feirtag JM. Effect of Oligosaccharides and fibre substitutes on short-chain fatty acid production by Human Faecal Microflora. Anaerobe. 2000;6:87-92.
-
(2000)
Anaerobe
, vol.6
, pp. 87-92
-
-
Velázquez, M.1
Davies, C.2
Marett, R.3
Slavin, J.L.4
Feirtag, J.M.5
-
122
-
-
0023276469
-
Short chain fatty acids in human large intestine, portal, hepatic and venous blood
-
1:STN:280:DyaL1c%2Fls1CrsA%3D%3D 3678950 1433442
-
Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut. 1987;28:1221-7.
-
(1987)
Gut
, vol.28
, pp. 1221-1227
-
-
Cummings, J.H.1
Pomare, E.W.2
Branch, W.J.3
Naylor, C.P.4
Macfarlane, G.T.5
-
123
-
-
0023743841
-
Short chain fatty acid distributions of enema samples from a sigmoidoscopy population: An association of high acetate and low butyrate ratios with adenomatous polyps and colon cancer
-
1:STN:280:DyaL1M%2Fpt1Wjuw%3D%3D 3209110 1433834
-
Weaver GA, Krause JA, Miller TL, Wolin MJ. Short chain fatty acid distributions of enema samples from a sigmoidoscopy population: an association of high acetate and low butyrate ratios with adenomatous polyps and colon cancer. Gut. 1988;29:1539-43.
-
(1988)
Gut
, vol.29
, pp. 1539-1543
-
-
Weaver, G.A.1
Krause, J.A.2
Miller, T.L.3
Wolin, M.J.4
-
124
-
-
84856509724
-
Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2
-
1:CAS:528:DC%2BC38XltVOlt7Y%3D 22190648 3266401
-
Tolhurst G, Heffron H, Lam YS, Parker HE, Habib AM, Diakogiannaki E, Cameron J, Grosse J, Reimann F, Gribble FM. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes. 2012;61:364-71.
-
(2012)
Diabetes
, vol.61
, pp. 364-371
-
-
Tolhurst, G.1
Heffron, H.2
Lam, Y.S.3
Parker, H.E.4
Habib, A.M.5
Diakogiannaki, E.6
Cameron, J.7
Grosse, J.8
Reimann, F.9
Gribble, F.M.10
-
125
-
-
84924700879
-
The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents
-
1:CAS:528:DC%2BC2cXhsFylsbvM
-
Psichas A, Sleeth ML, Murphy KG, Brooks L, Bewick GA, Hanyaloglu AC, Ghatei MA, Bloom SR, Frost G. The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents. Int J Obes (Lond). 2015;39:424-9.
-
(2015)
Int J Obes (Lond)
, vol.39
, pp. 424-429
-
-
Psichas, A.1
Sleeth, M.L.2
Murphy, K.G.3
Brooks, L.4
Bewick, G.A.5
Hanyaloglu, A.C.6
Ghatei, M.A.7
Bloom, S.R.8
Frost, G.9
-
126
-
-
84945202481
-
Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults
-
1:CAS:528:DC%2BC28XhtVKrsbbE 25500202
-
Chambers ES, Viardot A, Psichas A, Morrison DJ, Murphy KG, Zac-Varghese SEK, MacDougall K, Preston T, Tedford C, Finlayson GS, Blundell JE, Bell JD, Thomas EL, Mt-Isa S, Ashby D, Gibson GR, Kolida S, Dhillo WS, Bloom SR, Morley W, Clegg S, Frost G. Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut. 2015;64:1744-54.
-
(2015)
Gut
, vol.64
, pp. 1744-1754
-
-
Chambers, E.S.1
Viardot, A.2
Psichas, A.3
Morrison, D.J.4
Murphy, K.G.5
Zac-Varghese, S.E.K.6
MacDougall, K.7
Preston, T.8
Tedford, C.9
Finlayson, G.S.10
Blundell, J.E.11
Bell, J.D.12
Thomas, E.L.13
Mt-Isa, S.14
Ashby, D.15
Gibson, G.R.16
Kolida, S.17
Dhillo, W.S.18
Bloom, S.R.19
Morley, W.20
Clegg, S.21
Frost, G.22
more..
-
127
-
-
0027135109
-
Short-chain fatty acid content and pH in caecum of rats given various sources of carbohydrates
-
1:CAS:528:DyaK2cXltlGqsw%3D%3D
-
Berggren AM, Björck IME, Nyman EMGL, Eggum BO. Short-chain fatty acid content and pH in caecum of rats given various sources of carbohydrates. J Sci Food Agric. 1993;63:397-406.
-
(1993)
J Sci Food Agric
, vol.63
, pp. 397-406
-
-
Berggren, A.M.1
Björck, I.M.E.2
Nyman, E.M.G.L.3
Eggum, B.O.4
-
128
-
-
0031789297
-
Physiological effects of resistant starches on fecal bulk, short chain fatty acids, blood lipids and glycemic index
-
1:CAS:528:DyaK1MXmt1Ok 9853541
-
Jenkins DJ, Vuksan V, Kendall CW, Würsch P, Jeffcoat R, Waring S, Mehling CC, Vidgen E, Augustin LS, Wong E. Physiological effects of resistant starches on fecal bulk, short chain fatty acids, blood lipids and glycemic index. J Am Coll Nutr. 1998;17:609-16.
-
(1998)
J Am Coll Nutr
, vol.17
, pp. 609-616
-
-
Jenkins, D.J.1
Vuksan, V.2
Kendall, C.W.3
Würsch, P.4
Jeffcoat, R.5
Waring, S.6
Mehling, C.C.7
Vidgen, E.8
Augustin, L.S.9
Wong, E.10
-
129
-
-
26944502419
-
Oligofructose promotes satiety in rats fed a high-fat diet: Involvement of glucagon-like Peptide-1
-
1:CAS:528:DC%2BD2MXmvFWls7k%3D 15976142
-
Cani PD, Neyrinck AM, Maton N, Delzenne NM. Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like Peptide-1. Obes Res. 2005;13:1000-7.
-
(2005)
Obes Res
, vol.13
, pp. 1000-1007
-
-
Cani, P.D.1
Neyrinck, A.M.2
Maton, N.3
Delzenne, N.M.4
-
130
-
-
57049182455
-
Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents
-
1:CAS:528:DC%2BD1cXhsVWku77P 18796545 2584810
-
Zhou J, Martin RJ, Tulley RT, Raggio AM, McCutcheon KL, Shen L, Danna SC, Tripathy S, Hegsted M, Keenan MJ. Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents. Am J Physiol Endocrinol Metab. 2008;295:E1160-6.
-
(2008)
Am J Physiol Endocrinol Metab
, vol.295
, pp. E1160-E1166
-
-
Zhou, J.1
Martin, R.J.2
Tulley, R.T.3
Raggio, A.M.4
McCutcheon, K.L.5
Shen, L.6
Danna, S.C.7
Tripathy, S.8
Hegsted, M.9
Keenan, M.J.10
-
132
-
-
21244450727
-
Involvement of endogenous glucagon-like peptide-1(7-36) amide on glycaemia-lowering effect of oligofructose in streptozotocin-treated rats
-
1:CAS:528:DC%2BD2MXlsFeqt74%3D 15930172
-
Cani PD, Daubioul CA, Reusens B, Remacle C, Catillon G, Delzenne NM. Involvement of endogenous glucagon-like peptide-1(7-36) amide on glycaemia-lowering effect of oligofructose in streptozotocin-treated rats. J Endocrinol. 2005;185:457-65.
-
(2005)
J Endocrinol
, vol.185
, pp. 457-465
-
-
Cani, P.D.1
Daubioul, C.A.2
Reusens, B.3
Remacle, C.4
Catillon, G.5
Delzenne, N.M.6
-
133
-
-
33745126131
-
Improvement of Glucose Tolerance and Hepatic Insulin Sensitivity by Oligofructose Requires a Functional Glucagon-Like Peptide 1 Receptor
-
1:CAS:528:DC%2BD28XksFahur8%3D 16644709
-
Cani PD, Knauf C, Iglesias MA, Drucker DJ, Delzenne NM, Burcelin R. Improvement of Glucose Tolerance and Hepatic Insulin Sensitivity by Oligofructose Requires a Functional Glucagon-Like Peptide 1 Receptor. Diabetes. 2006;55:1484-90.
-
(2006)
Diabetes
, vol.55
, pp. 1484-1490
-
-
Cani, P.D.1
Knauf, C.2
Iglesias, M.A.3
Drucker, D.J.4
Delzenne, N.M.5
Burcelin, R.6
-
134
-
-
34547965812
-
Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats
-
1:CAS:528:DC%2BD2sXosVOjs7s%3D 17367575
-
Cani PD, Hoste S, Guiot Y, Delzenne NM. Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats. Br J Nutr. 2007;98:32-7.
-
(2007)
Br J Nutr
, vol.98
, pp. 32-37
-
-
Cani, P.D.1
Hoste, S.2
Guiot, Y.3
Delzenne, N.M.4
-
135
-
-
79960166870
-
Fatty acids as biocompounds: Their role in human metabolism, health and disease - A review. Part 1: Classification, dietary sources and biological functions
-
1:CAS:528:DC%2BC3MXht1ShsLzP 21804620
-
Tvrzicka E, Kremmyda L-S, Stankova B, Zak A. Fatty acids as biocompounds: their role in human metabolism, health and disease - a review. Part 1: classification, dietary sources and biological functions. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011;155:117-30.
-
(2011)
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub
, vol.155
, pp. 117-130
-
-
Tvrzicka, E.1
Kremmyda, L.-S.2
Stankova, B.3
Zak, A.4
-
136
-
-
13444263540
-
Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120
-
1:CAS:528:DC%2BD2MXptVSi 15619630
-
Hirasawa A, Tsumaya K, Awaji T, Katsuma S, Adachi T, Yamada M, Sugimoto Y, Miyazaki S, Tsujimoto G. Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med. 2005;11:90-4.
-
(2005)
Nat Med
, vol.11
, pp. 90-94
-
-
Hirasawa, A.1
Tsumaya, K.2
Awaji, T.3
Katsuma, S.4
Adachi, T.5
Yamada, M.6
Sugimoto, Y.7
Miyazaki, S.8
Tsujimoto, G.9
-
137
-
-
0032975814
-
Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects
-
1:CAS:528:DyaK1MXjs1Cjur8%3D 10357731
-
Thomsen C, Rasmussen O, Lousen T, Holst JJ, Fenselau S, Schrezenmeir J, Hermansen K. Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects. Am J Clin Nutr. 1999;69:1135-43.
-
(1999)
Am J Clin Nutr
, vol.69
, pp. 1135-1143
-
-
Thomsen, C.1
Rasmussen, O.2
Lousen, T.3
Holst, J.J.4
Fenselau, S.5
Schrezenmeir, J.6
Hermansen, K.7
-
138
-
-
0037371203
-
Differential effects of saturated and monounsaturated fats on postprandial lipemia and glucagon-like peptide 1 responses in patients with type 2 diabetes
-
1:CAS:528:DC%2BD3sXnsVSrtbk%3D 12600850
-
Thomsen C, Storm H, Holst JJ, Hermansen K. Differential effects of saturated and monounsaturated fats on postprandial lipemia and glucagon-like peptide 1 responses in patients with type 2 diabetes. Am J Clin Nutr. 2003;77:605-11.
-
(2003)
Am J Clin Nutr
, vol.77
, pp. 605-611
-
-
Thomsen, C.1
Storm, H.2
Holst, J.J.3
Hermansen, K.4
-
139
-
-
23844471668
-
Effects of an olive oil-enriched diet on plasma GLP-1 concentration and intestinal content, plasma insulin concentration, and glucose tolerance in normal rats
-
1:CAS:528:DC%2BD2MXkvF2nt74%3D 15888922
-
Prieto PG, Cancelas J, Villanueva-Peñacarrillo ML, Valverde I, Malaisse WJ. Effects of an olive oil-enriched diet on plasma GLP-1 concentration and intestinal content, plasma insulin concentration, and glucose tolerance in normal rats. Endocrine. 2005;26:107-15.
-
(2005)
Endocrine
, vol.26
, pp. 107-115
-
-
Prieto, P.G.1
Cancelas, J.2
Villanueva-Peñacarrillo, M.L.3
Valverde, I.4
Malaisse, W.J.5
-
140
-
-
33645711050
-
Effects of an olive oil-enriched diet on glucagon-like peptide 1 release and intestinal content, plasma insulin concentration, glucose tolerance and pancreatic insulin content in an animal model of type 2 diabetes
-
1:CAS:528:DC%2BD28XisFKqtr0%3D 16523410
-
Cancelas J, Prieto PG, Villanueva-Peñacarrillo ML, Valverde I, Malaisse WJ. Effects of an olive oil-enriched diet on glucagon-like peptide 1 release and intestinal content, plasma insulin concentration, glucose tolerance and pancreatic insulin content in an animal model of type 2 diabetes. Horm Metab Res. 2006;38:98-105.
-
(2006)
Horm Metab Res
, vol.38
, pp. 98-105
-
-
Cancelas, J.1
Prieto, P.G.2
Villanueva-Peñacarrillo, M.L.3
Valverde, I.4
Malaisse, W.J.5
-
141
-
-
34848878630
-
A MUFA-rich diet improves posprandial glucose, lipid and GLP-1 responses in insulin-resistant subjects
-
1:CAS:528:DC%2BD2sXht1WmsrvJ 17914131
-
Paniagua JA, de la Sacristana AG, Sánchez E, Romero I, Vidal-Puig A, Berral FJ, Escribano A, Moyano MJ, Peréz-Martinez P, López-Miranda J, Pérez-Jiménez F. A MUFA-rich diet improves posprandial glucose, lipid and GLP-1 responses in insulin-resistant subjects. J Am Coll Nutr. 2007;26:434-44.
-
(2007)
J Am Coll Nutr
, vol.26
, pp. 434-444
-
-
Paniagua, J.A.1
De La Sacristana, A.G.2
Sánchez, E.3
Romero, I.4
Vidal-Puig, A.5
Berral, F.J.6
Escribano, A.7
Moyano, M.J.8
Peréz-Martinez, P.9
López-Miranda, J.10
Pérez-Jiménez, F.11
-
142
-
-
29244458142
-
Free fatty acids administered into the colon promote the secretion of glucagon-like peptide-1 and insulin
-
1:CAS:528:DC%2BD2MXhtlCqtbfF 16356474
-
Adachi T, Tanaka T, Takemoto K, Koshimizu T, Hirasawa A, Tsujimoto G. Free fatty acids administered into the colon promote the secretion of glucagon-like peptide-1 and insulin. Biochem Biophys Res Commun. 2006;340:332-7.
-
(2006)
Biochem Biophys Res Commun
, vol.340
, pp. 332-337
-
-
Adachi, T.1
Tanaka, T.2
Takemoto, K.3
Koshimizu, T.4
Hirasawa, A.5
Tsujimoto, G.6
-
143
-
-
45849153782
-
Cloning and characterization of the rat free fatty acid receptor GPR120: In vivo effect of the natural ligand on GLP-1 secretion and proliferation of pancreatic beta cells
-
1:CAS:528:DC%2BD1cXnsVSqsbc%3D 18320172
-
Tanaka T, Yano T, Adachi T, Koshimizu T, Hirasawa A, Tsujimoto G. Cloning and characterization of the rat free fatty acid receptor GPR120: in vivo effect of the natural ligand on GLP-1 secretion and proliferation of pancreatic beta cells. Naunyn Schmiedebergs Arch Pharmacol. 2008;377:515-22.
-
(2008)
Naunyn Schmiedebergs Arch Pharmacol
, vol.377
, pp. 515-522
-
-
Tanaka, T.1
Yano, T.2
Adachi, T.3
Koshimizu, T.4
Hirasawa, A.5
Tsujimoto, G.6
-
144
-
-
84941414976
-
Fish oil and flax seed oil supplemented diets increase FFAR4 expression in the rat colon
-
1:CAS:528:DC%2BC2MXhtlCiur3K 26275932 4565737
-
Cheshmehkani A, Senatorov IS, Kandi P, Singh M, Britt A, Hayslett R, Moniri NH. Fish oil and flax seed oil supplemented diets increase FFAR4 expression in the rat colon. Inflamm Res. 2015;64:809-15.
-
(2015)
Inflamm Res
, vol.64
, pp. 809-815
-
-
Cheshmehkani, A.1
Senatorov, I.S.2
Kandi, P.3
Singh, M.4
Britt, A.5
Hayslett, R.6
Moniri, N.H.7
-
145
-
-
42949131619
-
Protein-induced satiety: Effects and mechanisms of different proteins
-
1:CAS:528:DC%2BD1cXlslyjs7k%3D 18282589
-
Veldhorst M, Smeets A, Soenen S, Hochstenbach-Waelen A, Hursel R, Diepvens K, Lejeune M, Luscombe-Marsh N, Westerterp-Plantenga M. Protein-induced satiety: effects and mechanisms of different proteins. Physiol Behav. 2008;94:300-7.
-
(2008)
Physiol Behav
, vol.94
, pp. 300-307
-
-
Veldhorst, M.1
Smeets, A.2
Soenen, S.3
Hochstenbach-Waelen, A.4
Hursel, R.5
Diepvens, K.6
Lejeune, M.7
Luscombe-Marsh, N.8
Westerterp-Plantenga, M.9
-
146
-
-
33644852682
-
Ghrelin and glucagon-like peptide 1 concentrations, 24-h satiety, and energy and substrate metabolism during a high-protein diet and measured in a respiration chamber
-
1:CAS:528:DC%2BD28Xptl2isw%3D%3D 16400055
-
Lejeune MP, Westerterp KR, Adam TC, Luscombe-Marsh ND, Westerterp-Plantenga MS. Ghrelin and glucagon-like peptide 1 concentrations, 24-h satiety, and energy and substrate metabolism during a high-protein diet and measured in a respiration chamber. Am J Clin Nutr. 2006;83:89-94.
-
(2006)
Am J Clin Nutr
, vol.83
, pp. 89-94
-
-
Lejeune, M.P.1
Westerterp, K.R.2
Adam, T.C.3
Luscombe-Marsh, N.D.4
Westerterp-Plantenga, M.S.5
-
147
-
-
41549102176
-
Energy Expenditure, Satiety, and Plasma Ghrelin, Glucagon-Like Peptide 1, and Peptide Tyrosine-Tyrosine Concentrations following a Single High-Protein Lunch
-
1:CAS:528:DC%2BD1cXjvValtrw%3D 18356323
-
Smeets AJ, Soenen S, Luscombe-Marsh ND, Ueland O, Westerterp-Plantenga MS. Energy Expenditure, Satiety, and Plasma Ghrelin, Glucagon-Like Peptide 1, and Peptide Tyrosine-Tyrosine Concentrations following a Single High-Protein Lunch. J Nutr. 2008;138:698-702.
-
(2008)
J Nutr
, vol.138
, pp. 698-702
-
-
Smeets, A.J.1
Soenen, S.2
Luscombe-Marsh, N.D.3
Ueland, O.4
Westerterp-Plantenga, M.S.5
-
148
-
-
84874040640
-
The G protein-coupled receptor family C group 6 subtype A (GPRC6A) receptor is involved in amino acid-induced glucagon-like peptide-1 secretion from GLUTag cells
-
1:CAS:528:DC%2BC3sXis1ajs7g%3D 23269670
-
Oya M, Kitaguchi T, Pais R, Reimann F, Gribble F, Tsuboi T. The G protein-coupled receptor family C group 6 subtype A (GPRC6A) receptor is involved in amino acid-induced glucagon-like peptide-1 secretion from GLUTag cells. J Biol Chem. 2013;288:4513-21.
-
(2013)
J Biol Chem
, vol.288
, pp. 4513-4521
-
-
Oya, M.1
Kitaguchi, T.2
Pais, R.3
Reimann, F.4
Gribble, F.5
Tsuboi, T.6
-
149
-
-
84876021542
-
Nutrition therapy
-
24070963
-
Dworatzek PD, Arcudi K, Gougeon R, Husein N, Sievenpiper JL, Williams SL. Nutrition therapy. Can J Diabetes. 2013;37 Suppl 1:S45-55.
-
(2013)
Can J Diabetes
, vol.37
, pp. S45-55
-
-
Dworatzek, P.D.1
Arcudi, K.2
Gougeon, R.3
Husein, N.4
Sievenpiper, J.L.5
Williams, S.L.6
-
150
-
-
84962438829
-
3. Foundations of Care and Comprehensive Medical Evaluation
-
American Diabetes Association
-
American Diabetes Association. 3. Foundations of Care and Comprehensive Medical Evaluation. Diabetes Care. 2015;39(Supplement 1):S23-35.
-
(2015)
Diabetes Care
, vol.39
, pp. S23-S35
-
-
-
151
-
-
84884268653
-
Acute effect of oatmeal on subjective measures of appetite and satiety compared to a ready-to-eat breakfast cereal: A randomized crossover trial
-
24024772
-
Rebello CJ, Johnson WD, Martin CK, Xie W, O'Shea M, Kurilich A, Bordenave N, Andler S, van Klinken BJW, Chu Y-F, Greenway FL. Acute effect of oatmeal on subjective measures of appetite and satiety compared to a ready-to-eat breakfast cereal: a randomized crossover trial. J Am Coll Nutr. 2013;32:272-9.
-
(2013)
J Am Coll Nutr
, vol.32
, pp. 272-279
-
-
Rebello, C.J.1
Johnson, W.D.2
Martin, C.K.3
Xie, W.4
O'Shea, M.5
Kurilich, A.6
Bordenave, N.7
Andler, S.8
Van Klinken, B.J.W.9
Chu, Y.-F.10
Greenway, F.L.11
-
152
-
-
84949625473
-
Instant Oatmeal Increases Satiety and Reduces Energy Intake Compared to a Ready-to-Eat Oat-Based Breakfast Cereal: A Randomized Crossover Trial
-
1:CAS:528:DC%2BC2MXhtlOhtbjF 26273900
-
Rebello CJ, Johnson WD, Martin CK, Han H, Chu Y-F, Bordenave N. Instant Oatmeal Increases Satiety and Reduces Energy Intake Compared to a Ready-to-Eat Oat-Based Breakfast Cereal: A Randomized Crossover Trial. J Am Coll Nutr. 2016;35:41-9.
-
(2016)
J Am Coll Nutr
, vol.35
, pp. 41-49
-
-
Rebello, C.J.1
Johnson, W.D.2
Martin, C.K.3
Han, H.4
Chu, Y.-F.5
Bordenave, N.6
-
153
-
-
79958036098
-
The impact of pistachio intake alone or in combination with high-carbohydrate foods on post-prandial glycemia
-
1:CAS:528:DC%2BC3MXmvFOksbg%3D 21364607
-
Kendall CWC, Josse a R, Esfahani a, Jenkins DJ a. The impact of pistachio intake alone or in combination with high-carbohydrate foods on post-prandial glycemia. Eur J Clin Nutr. 2011;65:696-702.
-
(2011)
Eur J Clin Nutr
, vol.65
, pp. 696-702
-
-
Kendall, C.W.C.1
Josse, A.R.2
Esfahani, A.3
Jenkins, D.A.4
-
154
-
-
84895779822
-
Acute effects of pistachio consumption on glucose and insulin, satiety hormones and endothelial function in the metabolic syndrome
-
1:CAS:528:DC%2BC2cXhtVOrsL0%3D 24424074
-
Kendall CWC, West SG, Augustin LS, Esfahani a, Vidgen E, Bashyam B, Sauder K a, Campbell J, Chiavaroli L, Jenkins a L, Jenkins DJ. Acute effects of pistachio consumption on glucose and insulin, satiety hormones and endothelial function in the metabolic syndrome. Eur J Clin Nutr. 2014;68:370-5.
-
(2014)
Eur J Clin Nutr
, vol.68
, pp. 370-375
-
-
Kendall, C.W.C.1
West, S.G.2
Augustin, L.S.3
Esfahani, A.4
Vidgen, E.5
Bashyam, B.6
Sauder, K.A.7
Campbell, J.8
Chiavaroli, L.9
Jenkins, A.L.10
Jenkins, D.J.11
-
155
-
-
84964314062
-
Effects of Pistachio Nut Supplementation on Blood Glucose in Patients with Type 2 Diabetes: A Randomized Crossover Trial
-
25396407 4310069
-
Parham M, Heidari S, Khorramirad A, Hozoori M, Hosseinzadeh F, Bakhtyari L, Vafaeimanesh J. Effects of Pistachio Nut Supplementation on Blood Glucose in Patients with Type 2 Diabetes: A Randomized Crossover Trial. Rev Diabet Stud. 2014;11:190-6.
-
(2014)
Rev Diabet Stud
, vol.11
, pp. 190-196
-
-
Parham, M.1
Heidari, S.2
Khorramirad, A.3
Hozoori, M.4
Hosseinzadeh, F.5
Bakhtyari, L.6
Vafaeimanesh, J.7
-
156
-
-
33845288948
-
Almonds decrease postprandial glycemia, insulinemia, and oxidative damage in healthy individuals
-
1:CAS:528:DC%2BD28XhtlSitr%2FM 17116708
-
Jenkins DJ a, Kendall CWC, Josse AR, Salvatore S, Brighenti F, Augustin LS a, Ellis PR, Vidgen E, Rao a V. Almonds decrease postprandial glycemia, insulinemia, and oxidative damage in healthy individuals. J Nutr. 2006;136:2987-92.
-
(2006)
J Nutr
, vol.136
, pp. 2987-2992
-
-
Jenkins, D.A.1
Kendall, C.W.C.2
Josse, A.R.3
Salvatore, S.4
Brighenti, F.5
Augustin, L.A.6
Ellis, P.R.7
Vidgen, E.8
Rao, A.V.9
-
157
-
-
44949239746
-
Effect of almonds on insulin secretion and insulin resistance in nondiabetic hyperlipidemic subjects: A randomized controlled crossover trial
-
1:CAS:528:DC%2BD1cXnt1ehtLo%3D 18555827
-
Jenkins DJ a, Kendall CWC, Marchie A, Josse AR, Nguyen TH, Faulkner D a, Lapsley KG, Singer W. Effect of almonds on insulin secretion and insulin resistance in nondiabetic hyperlipidemic subjects: a randomized controlled crossover trial. Metabolism. 2008;57:882-7.
-
(2008)
Metabolism
, vol.57
, pp. 882-887
-
-
Jenkins, D.A.1
Kendall, C.W.C.2
Marchie, A.3
Josse, A.R.4
Nguyen, T.H.5
Faulkner, D.A.6
Lapsley, K.G.7
Singer, W.8
-
158
-
-
80051788667
-
Almond ingestion at mealtime reduces postprandial glycemia and chronic ingestion reduces hemoglobin A1c in individuals with well-controlled type 2 diabetes mellitus
-
1:CAS:528:DC%2BC3MXhtVaitLvM 21489570
-
Cohen AE, Johnston CS. Almond ingestion at mealtime reduces postprandial glycemia and chronic ingestion reduces hemoglobin A1c in individuals with well-controlled type 2 diabetes mellitus. Metabolism. 2011;60:1312-7.
-
(2011)
Metabolism
, vol.60
, pp. 1312-1317
-
-
Cohen, A.E.1
Johnston, C.S.2
-
159
-
-
79251565829
-
Acute and second-meal effects of almond form in impaired glucose tolerant adults: A randomized crossover trial
-
1:CAS:528:DC%2BC3MXivVegt7Y%3D
-
Mori AM, Considine RV, Mattes RD. Acute and second-meal effects of almond form in impaired glucose tolerant adults: a randomized crossover trial. Nutr Metab (Lond). 2011;8:6.
-
(2011)
Nutr Metab (Lond)
, vol.8
, pp. 6
-
-
Mori, A.M.1
Considine, R.V.2
Mattes, R.D.3
-
160
-
-
77951643020
-
Consuming eggs for breakfast influences plasma glucose and ghrelin, while reducing energy intake during the next 24 hours in adult men
-
1:CAS:528:DC%2BC3cXjt1ers74%3D 20226994
-
Ratliff J, Leite JO, de Ogburn R, Puglisi MJ, VanHeest J, Fernandez ML. Consuming eggs for breakfast influences plasma glucose and ghrelin, while reducing energy intake during the next 24 hours in adult men. Nutr Res. 2010;30:96-103.
-
(2010)
Nutr Res
, vol.30
, pp. 96-103
-
-
Ratliff, J.1
Leite, J.O.2
De Ogburn, R.3
Puglisi, M.J.4
VanHeest, J.5
Fernandez, M.L.6
-
161
-
-
33644847802
-
Short-term effect of eggs on satiety in overweight and obese subjects
-
16373948
-
Vander Wal JS, Marth JM, Khosla P, Jen K-LC, Dhurandhar NV. Short-term effect of eggs on satiety in overweight and obese subjects. J Am Coll Nutr. 2005;24:510-5.
-
(2005)
J Am Coll Nutr
, vol.24
, pp. 510-515
-
-
Vander Wal, J.S.1
Marth, J.M.2
Khosla, P.3
Jen, K.-L.C.4
Dhurandhar, N.V.5
-
162
-
-
79961199068
-
The effects of consuming eggs for lunch on satiety and subsequent food intake
-
1:STN:280:DC%2BC3Mjislemtg%3D%3D 21495899
-
Pombo-Rodrigues S, Calame W, Re R. The effects of consuming eggs for lunch on satiety and subsequent food intake. Int J Food Sci Nutr. 2011;62:593-9.
-
(2011)
Int J Food Sci Nutr
, vol.62
, pp. 593-599
-
-
Pombo-Rodrigues, S.1
Calame, W.2
Re, R.3
-
163
-
-
84929606521
-
The Effect of an Egg Breakfast on Satiety in Children and Adolescents: A Randomized Crossover Trial
-
Liu a G, Puyau RS, Han H, Johnson WD, Greenway FL, Dhurandhar NV. The Effect of an Egg Breakfast on Satiety in Children and Adolescents: A Randomized Crossover Trial. J Am Coll Nutr. 2015;34:1-6.
-
(2015)
J Am Coll Nutr
, vol.34
, pp. 1-6
-
-
Liu, A.G.1
Puyau, R.S.2
Han, H.3
Johnson, W.D.4
Greenway, F.L.5
Dhurandhar, N.V.6
-
164
-
-
84888270482
-
A randomized 3 × 3 crossover study to evaluate the effect of Hass avocado intake on post-ingestive satiety, glucose and insulin levels, and subsequent energy intake in overweight adults
-
24279738 4222592
-
Wien M, Haddad E, Oda K, Sabaté J. A randomized 3 × 3 crossover study to evaluate the effect of Hass avocado intake on post-ingestive satiety, glucose and insulin levels, and subsequent energy intake in overweight adults. Nutr J. 2013;12:155.
-
(2013)
Nutr J
, vol.12
, pp. 155
-
-
Wien, M.1
Haddad, E.2
Oda, K.3
Sabaté, J.4
-
165
-
-
75549090101
-
Adaptation of colonic fermentation and glucagon-like peptide-1 secretion with increased wheat fibre intake for 1 year in hyperinsulinaemic human subjects
-
1:CAS:528:DC%2BD1MXhs1Smt73I 19664300
-
Freeland KR, Wilson C, Wolever TMS. Adaptation of colonic fermentation and glucagon-like peptide-1 secretion with increased wheat fibre intake for 1 year in hyperinsulinaemic human subjects. Br J Nutr. 2010;103:82-90.
-
(2010)
Br J Nutr
, vol.103
, pp. 82-90
-
-
Freeland, K.R.1
Wilson, C.2
Wolever, T.M.S.3
-
166
-
-
84941023299
-
Increased gut hormones and insulin sensitivity index following a 3-d intervention with a barley kernel-based product: A randomised cross-over study in healthy middle-aged subjects
-
1:CAS:528:DC%2BC2MXhsVegsrfN 26259632
-
Nilsson AC, Johansson-Boll EV, Björck IME. Increased gut hormones and insulin sensitivity index following a 3-d intervention with a barley kernel-based product: a randomised cross-over study in healthy middle-aged subjects. Br J Nutr. 2015;114:899-907.
-
(2015)
Br J Nutr
, vol.114
, pp. 899-907
-
-
Nilsson, A.C.1
Johansson-Boll, E.V.2
Björck, I.M.E.3
-
167
-
-
33846786399
-
Almonds and postprandial glycemia-A dose-response study
-
1:CAS:528:DC%2BD2sXhs1Clt7Y%3D 17292730
-
Josse AR, Kendall CWC, Augustin LSA, Ellis PR, Jenkins DJA. Almonds and postprandial glycemia-A dose-response study. Metabolism. 2007;56:400-4.
-
(2007)
Metabolism.
, vol.56
, pp. 400-404
-
-
Josse, A.R.1
Kendall, C.W.C.2
Augustin, L.S.A.3
Ellis, P.R.4
Jenkins, D.J.A.5
-
168
-
-
84877938161
-
Acute and second-meal effects of peanuts on glycaemic response and appetite in obese women with high type 2 diabetes risk: A randomised cross-over clinical trial
-
1:CAS:528:DC%2BC3sXnvVGhsbs%3D 23122211
-
Reis CEG, Ribeiro DN, Costa NMB, Bressan J, Alfenas RCG, Mattes RD. Acute and second-meal effects of peanuts on glycaemic response and appetite in obese women with high type 2 diabetes risk: a randomised cross-over clinical trial. Br J Nutr. 2013;109:2015-23.
-
(2013)
Br J Nutr
, vol.109
, pp. 2015-2023
-
-
Reis, C.E.G.1
Ribeiro, D.N.2
Costa, N.M.B.3
Bressan, J.4
Alfenas, R.C.G.5
Mattes, R.D.6
|